Elucidating the effects of shear stress on endothelial cell morphology and the expression of ENaC. by Lal, Pinky
 
Elucidating the effects of shear stress on 
endothelial cell morphology and the 






Pinky Lal BSc (Hons), NZDAP 
 
 
This thesis is submitted in fulfilment of the requirements for the degree of 
Master of Science in Physiology at the University of Otago. 
 
Department of Physiology, School of Biomedical Sciences,  
University of Otago, Dunedin  
New Zealand.  
6th June, 2019. 
II 
Abstract 
The epithelial sodium channel (ENaC) is important for blood pressure regulation through its 
function within the kidney and arteries, as it is a channel which facilitates the transportation of 
sodium into the intracellular environment of cells (Kashlan & Kleyman, 2011). ENaC has been 
reported in endothelial cells (ECs) as a prime candidate, facilitating endothelial function 
(Kusche-Vihrog et al., 2014a). ENaC is sensitive to mechanical forces such as laminar shear 
stress (LSS) and this may be important for endothelial-mediated-vascular function (Davies et 
al., 2005) In cardiovascular pathologies, LSS can become oscillatory (OSS), altering 
endothelial-mediated-vascular function, which may be associated with changes in ENaC 
(Davies, 2009). The aim of this project was to investigate the expression of ENaC and the 
change in morphology in endothelial cells, under shear stress with the addition of aldosterone 
and amiloride. 
Human endothelial cells (ECs) were cultured under LSS and OSS under shear stress magnitudes 
of 0, 5 and 10 dyns/cm2 for human umbilical vein endothelial cells (HUVECs) and 0, 10 and 
15 dyns/cm2 for human aortic endothelial cells (HAECs), using a cell culture perfusion system. 
Endothelial morphology was assessed using ImageJ, Fiji and Icy software. ENaC subunits (α, 
β, γ and δ) at mRNA were quantified using RT-qPCR.  
HAECs demonstrated a change in morphology in response to increasing shear stress (SS) and 
patterns of OSS but not LSS. For HUVECs, a change in morphology was noted under OSS and 
LSS with corresponding changes to the EC morphology. This project was able to establish the 
presence of all four ENaC subunits expression in HAECs using mRNA, which has not been 
shown previously. ENaC expression in HUVECs was found to be increased with varying SS 
magnitudes and patterns. The treatments of aldosterone and amiloride suggested preliminary 
changes in ENaC expression and with SS combined, changes were observed in EC morphology.  
Taken together, results from this project indicate that EC morphology is affected by SS and in 
particular by the different SS magnitudes and patterns of LSS or OSS. The quantified changes 
noted in ENaC expression could suggest a potential role for ENaC within the endothelium as 
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 1. Introduction 
2 
General overview: 
Shear stress (SS) is a mechanical, frictional force caused by the blood flow on the surface of 
endothelial cells (ECs) (Davies et al., 2005). For the ECs to respond to SS, a mechanism to 
detect and a signalling cascade to induce these responses must be present (Davies, 2009); 
however the mechanism and cascade are still under investigation. Within ECs there are a vast 
array of SS sensitive receptors (mechanosensor) including, ion channels i.e. the epithelial 
sodium channel (ENaC) which was identified to facilitate mechanotransduction. The exact 
mechanism of how ENaC senses SS is not fully understood. ENaC can be influenced by three 
factors, aldosterone, amiloride and SS (Wang et al., 2009 & Carattino et al., 2004). SS also 
induces changes in ECs; where cells align to the direction of flow (Ostrowski et al., 2014), 
change in shape, with cells becoming elongated (Kadohama et al., 2007)and increased in size 
(Oberleithner et al., 2003) due to cytoskeletal reorganisation (Yamamoto et al., 2003) (McCue 
et al., 2006) which could have ENaC involvement. 
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1.1. Shear Stress  
Shear stress (SS), is a frictional force generated/influenced by the blood flow. The frictional 
force is produced by the blood flowing tangentially to the apical surface of endothelial cells 
(ECs) (Davies, 1995; Davies et al., 2005). This project will be highlighting the effects of SS 
but will be acknowledging the effects of pressure as one force cannot be present without the 
other. Focusing on SS, this frictional force varies in the vasculature, as the venous system 
exhibits lower thresholds of SS (1- 6 dyns/cm2) in comparison to the arterial system where the 
threshold is higher (10 – 70 dyns/cm2) (Chiu & Chien, 2011).  
SS also varies in pattern where laminar shear stress (LSS) is present within blood vessels 
regulating vascular homeostasis (Traub & Berk, 1998) and oscillatory shear stress (OSS) is 
predominantly found at bifurcations and curvatures of large blood vessels such as arteries and 
aorta under physiological conditions or if there is a plaque deposition (Cunningham & Gotlieb, 
2005). Dysfunction within the SS can result in the development of pathogenesis of vascular 
diseases i.e. impairment in the endothelial dependent vasodilation leads to the onset of cellular 
stiffening. This is usually due to the EC becoming stiff as a result of decreased nitric oxide 
production via an increase in inflammation within the cells (Jeggle et al., 2013). A shift from 
LSS to OSS has been implicated in cardiovascular pathologies (i.e. stenosis and occluded 
arteries), with OSS ultimately leading to changes in gene expression, increasing atherogenic 
genes transcription (Jiang et al., 2000).  
SS activates a number of signal transduction pathways; however in order for this to occur, 
transmission of the mechanical force must occur via a) mechanosensors and b) the signal must 
be converted into a biochemical signal (Hahn & Schwartz, 2009). This phenomena has been 
described as mechanotransduction. Mechanotransduction in the endothelium has been 
described as either 1) transmission of the force to specialized structures, 2) transduction of the 
force into biochemical signals and 3) the consequent response of the cell (Alonso & Goldmann, 
2016). Cells in general, have been identified to translate the mechanical stimuli into intracellular 
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signals which in turn regulate the cell process (Johnson et al., 2011). Despite noting the 
importance of mechanical signalling in biology, the knowledge is still limited and under 
investigation. 
The exact signaling pathway is not fully understood; however the mechanobiology of the 
endothelium could facilitate the response to SS. The term mechanobiology can be separated 
into the EC mechanics and mechanical stimuli. ECs are constantly exposed to various 
mechanical forces (stimuli) generated by the blood flow i.e. pressure and SS. These forces affect 
EC function via mechanotransduction, activation of mechanosensitive signaling pathways. 
Activation of these pathways usually are triggered via mechanosensor including, 
mechanosensitive ion channels, adhesion proteins, and extracellular matrix (Hamill & 
Martinac, 2001) (Bazopoulou et al., 2007; Deng et al., 2014). The ECs mechanics describes the 
mechanical properties of the cell including the cell stiffness. ECs have been reported to 
demonstrate sensitivity, by increasing stiffness to changes in mechanical forces (Hahn & 
Schwartz, 2009). The following section focuses on ECs and their purpose within the 
vasculature.  
1.2 Endothelial cells  
Endothelial cells (ECs) have been identified as a selective barrier and key regulator of blood 
flow within the arterial and venous vasculature (Chien, 2007) (Deng et al., 2014). Anatomically, 
ECs are made of a plasma membrane consisting of a double layer of phospholipids, contractile 
proteins including actin, myosin and tropomyosin which make up the cytoskeleton and also 
enable motor activities (Wechezak et al., 1985; Prystopiuk et al., 2018). The contractile proteins 
are organized within the cortex of the ECs allowing for contraction and relaxation, regulating 
the cell morphology in response to mechanical stimuli (Potter et al., 2012). The endothelium 
has been reported to synthesize and release endothelium derived vasodilatory and constrictive 
factors in response to mechanical stimuli (Gurovich et al., 2014). Among these factors, one 
 1. Introduction 
5 
signal molecule is involved and a target to many pathways and mechanism: nitric oxide (NO) 
(Boo & Jo, 2003). Within the endothelium, NO is synthesized from the amino acid L-arginine 
and by the calcium-calmodulin-dependent enzyme nitric oxide synthase (eNOS) (Vallance & 
Hingorani, 1999; Pérez et al., 2009). NO acts on a wide range of endothelial properties 
including: endothelial-dependent vasodilation (Paniagua et al., 2001), regulation of cell growth 
(Kirsch et al., 2013), and platelet aggregation (Hanke & Campbell, 2000). ECs synthesize and 
respond to other factors as well which maintain anti-inflammatory, anti-thrombotic and non-
adhesive properties of the endothelial barrier (Luiking et al., 2010). By maintain these 
properties, ECs contribute towards regulating angiogenesis, fluid balance and permeability. 
Disruption in these properties, of the endothelium can lead to the development of endothelial 
dysfunction (Cai & Harrison, 2000). This is discussed in the following section.  
1.2.3 Endothelial dysfunction  
Endothelial dysfunction is defined by a reduction in the endothelial-dependent vasodilation 
(Nishizaka et al., 2004), but not limited to it. Previous studies have demonstrated the ECs to 
enter a state of pro-inflammation, pro-thrombotic and adhesive state associated with endothelial 
dysfunction (Cai & Harrison, 2000; Luca et al., 2010). It is reported that in pathological states 
such as atherosclerosis, the ECs typically generate an excess in vasoconstrictive factors and/or 
vasodilatory factors. One established mechanism is the impaired NO production under disease 
states which leads to downstream effects within the vascular smooth muscle (VSMC). The 
effects within the VSMC is reported as an imbalance between constriction and dilatory factors. 
There is an exacerbation in vasoconstriction within the VSMC, which would lead to increased 
resistance within the whole vessel and further develop into hypertension, if uncontrolled for. 
The underlying mechanisms are not fully understood as to why there is a shift of the actions of 
the endothelium towards reduced vasodilation; however the current literature does identify SS 
as a modulator of endothelial function and an increase or decrease is linked to the onset of 
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endothelial dysfunction(Davies et al., 2005; Davies, 2009). The following section will discuss 
the effects of SS on the endothelium and how it responds to SS.  
1.2.4 The effect of SS on the endothelium  
ECs are evolutionary equipped to transduce SS into metabolic, humoral and structural response 
(McCue et al., 2006). Mechanical forces are detected by sensors which are distributed in 
different parts, including cell–cell junction, cytoplasm, nucleus and the cell membrane 
(Kadohama et al., 2007; Oberleithner et al., 2003;Yamamoto et al., 2003; McCue et al., 2006).. 
These sensors function to regulate and maintain vascular homeostasis such as endothelial 
dependent vasodilation (Nishizaka et al., 2004; Jeggle et al., 2013). Conversion of the forces 
into secondary signals is seen via mechanotransduction which is the response generated by an 
organism to a mechanical stimuli.  
SS is essential in maintaining the endothelial barrier and regulate the functions to provide a 
balance in the vaso-dilatory and constriction factors. Dysfunction within the SS can result in 
the development of pathogenesis of vascular diseases i.e. onset of cellular stiffening associated 
with a reduction in NO (Jeggle et al., 2013). Disruption in the endothelial monolayer can also 
occur, alongside a reduction in the proliferation of ECs. This has been demonstrated within 
arteries effected by atherosclerosis where the SS has become unregulated and exacerbates the 
upregulation of atherogenic factor e.g. inflammatory markers, adhesive molecules. The 
endothelium itself also under goes changes including changes to the morphology in an adaptive 
mechanism to SS. This is discussed in the following section.  
1.2.3 SS effect on endothelial morphology  
ECs respond to SS via a change in cytoskeletal arrangement. The mechanical properties of the 
ECs play a key role in regulating this response but also enable the EC to undergo conformational 
changes in response to SS (Okano & Yoshida, 1993). Previous studies have reported that ECs 
to undergo changes in cell shape, alignment and cytoskeletal remodeling in the direction of flow 
(Flaherty et al., 1972) (Levesque & Nerem, 1985). Malek and colleagues, reported endothelial 
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response of alignment and morphology changes to be dependent intracellular calcium and 
tyrosine kinase activity (Malek & Izumo, 1996). It has been widely accepted that vascular ECs 
become elongated and aligned to the direction of flow when exposed to SS. Kataoka and 
colleagues demonstrate the morphological change on bovine aortic ECs where under no flow 
(no SS) the appearance of ECs was similar to that of cobble stones. With the application of SS, 
under 20 mins the ECs displayed elongation and within 1-3 hrs of exposure the ECs 
demonstrated orientation to the direction of flow (Kataoka et al., 1998). These changes in 
morphology have been linked to the distribution in cytoskeleton of the ECs and Ookawa and 
colleagues have been able to demonstrate a change in actin filaments within ECs with the 
exposure of SS before visual morphological changes occurred (Ookawa et al., 1992). In 
previous projects conducted in the Fronius Lab, ECs exposed to SS have been reported to 
undergo cell morphology changes and observed to align in the direction of flow (Unpublished 
data). For this project, changes to the endothelial morphology was one of the objective as it will 
be highlighted further.  
1.3 Mechanosensors within the endothelium  
Mechanotransduction occurs under the application of pressure and SS, it is important to 
understand the role of the force transducing molecules which are highly specialized structures 
allowing organisms to sense mechanical forces (Bazopoulou et al., 2007). Force transducing 
molecules have been identified to sense and initiate a secondary response within cellular 
environments (Drummond et al., 2004). Several studies have found, ion channels, plasma 
membrane, cytoskeleton and glycocalyx proteins to be part of the mechanosensors within the 
endothelium (Huang & Chalfie, 1994; Drummond et al., 2004; Frey et al., 2009). For this 
project the focus will be made on ion channels, in particular the epithelial sodium channel which 
has recently been implicated as a potential sensor to SS. Genetic screenings of the nematode 
Caenorhabditis elegans (C. elegans) has led to the identification of several genes which consist 
among others of subunits that are likely to assemble mechanically gated ion channels 
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(Tavernarakis & Driscoll, 2001). Genetic studies have suggested these mechanosensitive 
subunits within the C. elegans to belong to a large family of related proteins referred to as 
degenerins (Driscoll & Tavernarakis, 1997; Tavernarakis & Driscoll, 2001). These subunits 
share similar traits found within the epithelial sodium channel. The next section will discuss 
further about the channel and its potential role in ECs and under SS. 
1.4 The epithelial sodium channel (ENaC)  
The epithelial sodium channel, (ENaC) is a heterotrimeric membrane protein, composed of 3 
different homologous subunits, alpha (α), beta (ß) and gamma (γ). A fourth ENaC subunit delta 
(δ), was identified in humans and was first reported the expression in human tissues (Hanukoglu 
& Hanukoglu, 2016), including the ovaries, pancreas, brain (Waldmann et al., 1995) and the 
endothelium (Golestaneh et al., 2001) To date, the delta ENaC expression has not been found 
within rodent models, which makes δ highly relative to humans. The δ subunit has a similar 
amino acid sequence to α ENaC (~37% identity), and is able to form a channel alone or in 
combination with ß and γ ENaC (Ji et al., 2012). 
ENaC belongs to the superfamily of DEG/ENaC. The name of the DEG/ENaC family is derived 
from the first identified degenerins (DEG) protein found in C. elegans and the vertebrae 
epithelial sodium channel (ENaC) (Noreng et al., 2018). The members of the DEG/ENaC 
family have been identified as strong candidates for mechanotransduction due to the conserved 
evolutionary trait. (Kizer et al., 1997; Tavernarakis and Driscoll, 1997; Benos and Stanton, 
1999; Mano and Driscoll, 1999). In particular, the subunits MEC-4 and MEC-10 form the core 
of the mechanosensory channel complex (Corey et al., 1996). Touch studies in C. elegans have 
postulated the DEG/ENaC subunits MEC-4 and MEC-10 to be linked to the extracellular matrix 
enabling the mechanical activation of the ion channels (Tavernarakis and Driscoll, 1997; Benos 
and Stanton, 1999; Mano and Driscoll, 1999). Members of the DEG/ENaC superfamily are 
expressed in human/vertebrae tissues as the kidney epithelia, muscle cells, neurons and most 
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recently in the vascular smooth muscle cells (VSMC) (Grifoni et al., 2006) and endothelial cells 
(ECs) (Golestaneh et al., 2000; Oberleithner et al., 2007; Korte et al., 2014).  
A functional ENaC channel has been reported to comprise of α ENaC alone or ßγ ENaC, 
evoking measurable currents (Canessa et al., 1994) The α subunit is essential for the proper 
channel function, where as ß and γ amplify the channels activity (Kusche-Vihrog et al., 2008a). 
The δ subunit has been described in 2 different forms, δ1 and δ2 (Haerteis et al., 2009), where 
differences lies in the N termini. The difference in the δ splice variants is the length of amino 
acids. The shorter form of δ is ~638 amino acids, cloned from the kidney and the longer form 
is ~ 704 amino acids long, cloned from the human testis (Haerteis et al., 2009). 
1.4.1. Physiology of ENaC  
Physiologically, ENaCs role is to transport Na+ from the extracellular environment as it is 
highly selective for Na+. Typically, this also facilitates the movements of water across the cell 
membrane via osmosis/diffusion (Hanukoglu I & Hanukoglu, 2016). ENaC is located on the 
apical membrane of epithelial and endothelial cells and differs in its role depending on its 
location of expression. In the kidney, filtered Na+ is reabsorbed by the collecting duct, which is 
a rate-limiting step for salt reabsorption. This function facilitates the control of total body salt 
and water homeostasis which in turn regulates blood pressure. In the airway, ENaC is important 
for modulating surface mucous clearance. Mutations within ENaC can result in disease, causing 
an increase or decrease in ENaC activity, such as Liddle’s syndrome or Cystic fibrosis 
(Furuhashi et al., 2005). ENaC within the endothelium is not fully understood, but its potential 
role is discussed in section 1.6 as it is part of this project.  
1.5. Regulation of ENaC  
ENaC can be regulated by different intrinsic and extrinsic factors that affect the expression, 
function and trafficking (Wang et al., 2009 & Carattino et al., 2004).. For this project three 
factors, aldosterone, amiloride and SS have been selected to study the effect on ENaC 
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expression and endothelial morphology. These three factors individually influence ENaC which 
can be represented through the equation seen in equation 1. Aldosterone, an agonist, regulates 
ENaC expression and activity. Amiloride, a pharmacological drug, inhibits ENaC activity, 
resulting in decreased Na+ reabsorption (Satlin et al., 2001 & Althaus et al., 2007). (Kusche-
Vihrog et al., 2008b). SS influences ENaC via the open state probability (Po) through flow 
mediated stimuli (i.e. mechanical stress). The Po is a measure of the proportion of the total 
recording time that an ion channel spends in its open state. The following sections have been 
divided to focus on the factors individually and highlighting the knowledge on the effect of 
ENC and ECs.  
Equation 1. The function of ion channels represented by ion current (I) can be 
summarized by the following principle:  
I = N x Po 
I = Current of the ion channel  
N = Number of ion channel 
Po = Open state probability  
 
1.5.1 SS regulates ENaC activity via the open state probability (Open probability - Po)  
SS generated from fluid flowing on the surface of cells regulates the open state probability of 
ENaC (Wang et al., 2009; Sakamoto et al., 2010). Within the epithelia there are a vast array of 
mechanosensitive receptors including, ion channels i.e. ENaC (Davies, 2009) which could 
facilitate mechanotransduction (Chien, 2007). In 2001, Satlin et al demonstrated Na+ absorption 
via cortical collecting ducts within the kidney under tubular perfusion. Increasing perfusion rate 
exhibited an increase in the Na+ reabsorption (Satlin et al., 2001). Xenoupus laevis oocytes 
expressing mouse ENaC were also stimulated by bath perfusion, providing evidence of ENaC 
activation by flow mediated mechanical stress (Satlin et al., 2006). The concept of ENaC having 
mechanosensitive properties was initially derived from the Degenerins superfamily: however, 
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the exact mechanism of how ENaC might sense is being investigated. Although recently, 
extracellular loops of ENaC have become the prime focus of ENaCs ability to facilitate a 
response to SS (Fronius & Clauss, 2008). These channel structures, found within the luminal 
compartment could detect the fluid flow, coupled with the gating mechanism of ENaC, causing 
conformational change (Fronius et al., 2010). Therefore, this change induces an increase in the 
open state probability, which in turn influences the rate of Na+ absorption through the channel 
pore (Knoepp et al., 2017) . Electrophysiological recordings have displayed an increase in the 
open state probability with application of flow, which elucidates ENaC as a candidate of sensing 
SS (Wang et al., 2009).  
1.5.2 Aldosterone regulates ENaC expression (Number - N)  
Aldosterone, a hormone within the human body is secreted at a plasma concentration of ~10nM 
(Oberleithner et al., 2003). Predominantly aldosterone has been found to facilitate the 
transcription of aldosterone induced proteins such as serum and glucocorticoid-regulated kinase 
1 (SGK1) and ENaC (Verrey et al., 2003). Aldosterone mediates its function via the mineral 
corticoid receptor (MR), located in the cytosol of the cell. The molecular mechanism of 
aldosterone involves it binding to the MR which translocate into the nucleus, binding to the 
transcription domain, regulating gene transcription (Vallon et al., 2005). The molecular 
mechanism of aldosterone is seen across 2-time phases. The early phase occurs within 0.5-3 hrs 
of aldosterone application in which there is a 2-3-fold increase in sodium reabsorption (Lai et 
al., 2007). During the early phase, SGK1 phosphorylates Nedd4-2, a ubiquitin-protein ligase; 
that prevents ENaC retrieval from the plasma membrane and increases ENaC current. At the 
gene level, ENaC transcription is seen to have a small increase. After ~3hours, the late phase 
of aldosterone stimulates a larger fold change in ENaC gene expression with an increase up to 
20 folds after 24 hours of aldosterone application (Oberleithner et al., 2003). It is important to 
note that a change in gene expression does not always translate into a change in protein 
expression within the cell or membrane surface.  
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1.5.3.1 The effect of aldosterone in the endothelium 
Aldosterone within the arteries has a variety of effects. Some of these effects include, increase 
in EC volume, increase in ENaC expression and recently modulates endothelial permeability 
and nitric oxide production via rearranging the cytoskeleton. As mentioned previously, 
aldosterone regulates gene transcription, upregulating ENaC expression, enabling the cells to 
swell with an increase in water absorption (Oberleithner et al., 2004a). Kirsch and colleagues 
have recently demonstrated that aldosterone temporally increases permeability and rearranges 
the cytoskeleton, along with junctional proteins of ECs. These changes have been reported to 
decrease eNOS activity leading to a reduction in NO production (Kirsch et al., 2013). Junctional 
proteins are important for junction control within ECs and impairment in the function can result 
in pathologies i.e. tumour inducing angiogenesis (Le Guelte et al., 2011). 
1.5.4 Amiloride, an inhibitor of ENaC activity (Current - I)  
Amiloride, a pharmacological ENaC antagonist, binds reversibly to the outer pore of ENaC 
blocking the absorption of Na+ (Martinez-Lemus et al., 2017). Amiloride has a high affinity 
binding to the pore of α ENaC, hence the effect on the Na+ current is rapid. But with δ ENaC, 
the affinity is lower, therefore an increased concentration of the drug is required to inhibit the 
channel (Kellenberger et al., 2003; Oberleithner et al., 2003). In addition, amiloride has aalso 
been observed to reduce ENaC expression in cells when applied over longer time periods (12-
24 hours). Cells pre-treated with aldosterone, had an addition of amiloride, which reduced 
ENaC abundance by a total of 84% and expression at the apical surface by 44% (Kusche-Vihrog 
et al., 2008b). This indicates that an aldosterone induced increase of ENaC protein expression 
is reversible by the application of amiloride but may also target aldosterone-independent 
mechanisms of ENaC expression. However, this requires further investigation to be fully 
confirmed.  
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1.5.4.1 The effect of amiloride in the endothelium 
Amiloride, pharmacologically is used as an anti-diuretic, inhibiting water absorption for 
hypertensive patients. Within the arteries, amiloride reduces ENaC abundance particularly in 
mesenteric arteries of female mice, but enhances the endothelial dependent dilation (Marshall 
et al., 2017) This can be explained by the antagonist effect of amiloride which has been shown 
to improve vasodilatory signals (nitric oxide production). Similarly in rat carotid arteries, 
amiloride enhances endothelium dependent dilation with an increase in the inner luminal 
diameter (Ashley et al., 2018). The amiloride effect was endothelial dependent and not vascular 
smooth muscle, as the response was diminished by removing the endothelium (Ashley et al., 
2018). This evidence would strongly suggest, ENaC involvement in the initiation of 
vasodilation. However more investigation is required to clarify the role of ENaC in endothelial 
dependent vasodilation and whether SS has a direct or an indirect effect on the channels role in 
blood vessels. This will be investigated in this project with the application of amiloride on to 
EC with and without the application of SS.  
1.6. ENaC as a mechanosensor in endothelial cells 
There is emerging evidence implicating ENaC as a mechanosensitive ion channel (Jeggle et al., 
2013 & Jernigan & Drummond et al., 2005). Endothelial responsiveness to SS is essential for 
vascular function. Although limited knowledge is available about ENaCs function in EC’s, the 
channel has been shown to indirectly modulate vascular tone (Jeggle et al., 2013 & Jernigan & 
Drummond et al., 2005), and vascular resistance. Studies on ion channel activation within the 
endothelium have alluded to the change in the EC membrane potential. ECs are non-excitable 
cells but exhibit a membrane potential (Li et al., 2012; Gerhold et al., 2006). This potential 
regulates voltage dependent channels i.e. potassium channels and other cation channels and 
activation in response to SS leads to the increase in intracellular calcium concentration (White 
et al., 2000). In human umbilical vein endothelial cells (HUVECs), SS as low as 5 dyns/cm2 
has activated cation channels and making the ECs permeable to calcium into the cytosol (Tran 
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et al., 2000). This calcium release along with other secondary messenger’s initiate a cascade of 
response i.e cell stiffening, proliferation and regulation of nitric oxide production (Gerhold et 
al., 2006). Whether ENaC elucidated a secondary messenger response to SS is unknown within 
the endothelium. This could be since flow induced currents to date have only been studied in 
response to short time periods of stimulation. In vivo, ECs are exposed to SS chronically and in 
the presence of sustained SS, ion channels might become desensitised (Gerhold et al., 2006; 
White et al., 2000). Therefore, it would be essential to establish longer exposure of SS to 
understand the effects on the endothelium and in particular on ENaC expression.  
ENaC expression has been associated to EC stiffening, leading onto impaired flow mediated 
dilation (Korte., et al 2014). This impairment was hypothesised to be interrelated to the 
increased influx of Na+ which stiffens the EC cortex, attenuating the nitric oxide production 
(Perez et al., 2009). It has been reported, ECs exposed to high LSS to migrate against the 
direction of fluid flow, proliferating in regions of peak high LSS, whereas in low LSS, ECs 
migrate in perpendicular orientation to flow (Ostrowski et al., 2014). Thus, signifying a 
mechanotransduction pathway of transducing SS into a biochemical signal, inducing cellular 
changes. Preliminary results from Fronius lab have shown that ENaC is expressed in an in vitro 
cell line (human umbilical vein endothelial cells) at both the messenger RNA and protein level. 
Changes in SS, particularly from LSS to OSS have been shown to increase β and γ ENaC 
subunits (Summer Research). This indicates ENaC expression responds to SS; however, more 
research is required to investigate this further. 
For this project, a perfusion system has been used to elucidate the effects of SS on the 
expression of ENaC within the endothelium. Ideally, patch clamp protocols overs a long period 
of SS exposure would outline ENaC role as a mechanosensor, but the protocol itself is difficult 
to maintain. Therefore, the use of a cell culture perfusion system will enable the investigation 
of ENaC at the messenger RNA and protein level in response to SS.  
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1.7 Aims and Objectives 
Aim: To investigate the expression of ENaC and the change in morphology in endothelial 
cells, under shear stress with the addition of aldosterone and amiloride. 
Human umbilical vein endothelial cells and aortic endothelial cells will be used to carry out the 
following objectives  
Objective 1: Analyses of endothelial morphology under different SS and treatment 
(Aldosterone and Amiloride) by:  
Assessment of: 
a. Cell alignment to the direction of flow (angle)  
b. Determining the cell elongation ration (long axis/short axis) under different SS 
conditions 
c. Quantify the whole cell area in response to SS and the treatment of aldosterone and 
amiloride.  
Objective 2: Analyses of ENaC gene expression in EC under different SS and treatment 
(Aldosterone and Amiloride) conditions:  
a. Messenger RNA expression levels for α, β, γ, δ ENaC  
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1.7 Hypothesis  
1.7.1. Objective 1.  
The aim for this objective is to investigate the effect of SS on the endothelial morphology, on 
the cell angle alignment, endothelial elongation and whole cell area in response to the direction 
of flow. The hypothesis for this objective is: 
• Increasing the magnitude of SS will cause ECs angle to align to the direction of flow, 
ECs will be elongated and whole cell area will be reduced.  
• Changing the SS pattern from LSS to OSS will not cause ECs angle to align to the 
direction of flow, ECs will be reduced in elongation and whole cell area will be 
increased.  
• Treating HUVECs with aldosterone will cause ECs angle to not align to the direction of 
flow, EC elongation will be reduced and whole cell area will be increased.  
• Treating HUVECs with amiloride will cause ECs to align to the direction of flow, ECs 
will be elongated; whole cell area will be reduced.  
1.7.2. Objective 2.  
• HAECs will express ENaC and increasing the magnitude of SS will lead to an increase 
in ENaC expression. 
• Increasing the magnitude of SS will lead to an increase in ENaC gene expression in 
HUVECs. 
• Changing SS pattern from LSS to OSS will induce an increase in ENaC gene expression 
in HAECs and HUVECs  
• Treating HUVECs with aldosterone will induce an increase in ENaC gene expression 
and treating HUVECs with amiloride will induce a decrease in ENaC gene expression. 
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2.1 Cell Culture  
Two mammalian cell lines were used, human umbilical vein endothelial cells (HUVECs) and 
human aortic endothelial cells (HAECs). These cell lines were used to study the expression of 
ENaC under various shear stress conditions, using the commercially available integrated ibidi 
cell culture perfusion system (ibidi, Munich, Germany). 
2.1.1 Human umbilical vein endothelial cells (HUVEC) 
Primary human umbilical vein endothelial cells (HUVEC) (ATCC, Manassas, USA Cat No. 
PCS-100-013) were cultured according to the manufacturer’s protocol. Cells were cultured in 
Endothelial Basal Medium 2 (EBM-2, Lonza, Basel, Switzerland Cat# CC-3202). The medium 
had additional supplements including EGM-2 Single-Quots (Lonza, Basel, Switzerland Cat# 
CC-4176). containing Human Epidermal Growth Factor (HEGF), Vascular Endothelial Growth 
Factor (VEGF), R3-Insulin Growth Factor-1 (R3-IGF-1) Ascorbic Acid, Hydrocortisone, 
Human Fibroblast Growth Factor-Beta (HFGF-Β), Heparin, 2% Fetal Bovine Serum and 
Gentamicin/Amphotericin B (GA) (Lonza, Basel, Switzerland Cat# CC-4176) all which were 
mixed into the medium. Penicillin-Streptomycin (5,000 U/mL) was also added to the medium 
as antibiotic protection (Thermofisher, Auckland, NZ Cat # 15070063). HUVEC cell passages 
number between 2 to 8 were used for experiments as any passage no. above 8 did not respond 
to proliferation and would enter a senesces state.  
2.1.2 Human aortic endothelial cells (HAEC) 
Primary human aortic endothelial cells (HAEC) (ScienCell, California, USA Cat No. 6010). 
HAECs were cultured under manufactures protocol and cultured using the same medium as the 
HUVECs (EBM-2, Lonza, Basel, Switzerland Cat# CC-3202) with additional penicillin-
streptomycin (Thermofisher, Auckland, NZ Cat # 15070063). HAECs passages between 3 and 
6 were used for experiments as passages no. above 6 entered a senesces state.   
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2.1.3 Initiating frozen endothelial cells 
The ECs were delivered as frozen aliquots to the University of Otago. These frozen aliquots of 
ECs of HAECs (containing 5 x105 cells/cm2 in 1 mL) and HUVECs (containing 2 x 104 to 4 x 
104 viable cells/cm2 in 1 mL)were quickly thawed in a 37°C water bath, along with the EC 
medium as it was stored in a 4°C fridge. Following the heating process, 1 mL of the cell solution 
was added to 5 mL of EGM-2 media in a pretreated T-25 flask (Lab Supply, Dunedin, NZ Cat# 
GRE690175). The EC medium equilibrated to incubator conditions 5% CO2, 20% O2 at 37°C 
for 30min. Cells were placed in the incubator with 5% CO2, 20% O2 at 37°C (Aztec, Fukuoka, 
Japan) for a period of 24 hrs, with media changed every 24 hrs.  
2.1.4 Subculture of endothelial cells  
Once the ECs reached approximately 80% confluency (HUVECs take 48 hrs, HAECs take 2-4 
days), confirmed by visual inspection through microscope, cells were sub-cultured in a sterile 
cell culture hood (laminar air flow bench). The EBM-2 media was aspirated using a vacuum 
located within the culture hood, from the T-25 flask and gently washed with 2 mL sterile 
phosphate buffer solution (PBS) (Sigma-Aldrich, Darmstadt, Germany Cat# P4417) (37°C). 
ECs had 2 mL of Trypsin-EDTA phenol red (0.25%) (ThermoFisher Auckland, NZ Cat# 
25200056), was added at 37°C for 3-4 min. The purpose of Trypsin is to act as a recombinant 
enzyme used for dissociating adherent mammalian cells. The flask containing ECs was also 
tapped to allow for further dissociation of cells.  
Microscopic inspection of >90% detachment was confirmed before the EGM-2 (37°C) media 
was added to stop the enzyme activity of Trypsin. The EC suspension was then centrifuged at 
200 RCF (Centrifuge 5430R, Eppendorf, Germany) for 5 mins. The supernatant was aspirated 
and discarded. The EC pellet was re-suspended in 2 mL of EGM-2 media and the number of 
cells were counted using an automated hemocytometer (Countess II Automated cell counter, 
Thermofisher, UK). ECs were re-seeded at a density of 2,500 cells/cm2 to freshly prepared T-
25 flasks (containing EGM-2 media). Cells were incubated at 5% CO2, 20% O2 at 37°C. After 
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24 hrs, EC medium was aspirated, and fresh medium was added. Thereafter, culture media was 
changed every 2 to 3 days, until use in experiments or reached 80% confluency, where the 
subculture process was repeated which took a period of 1 hr. HUVECs were sub cultured until 
passage 8 and HAECs were sub cultured until passage 6, after which the cells were discarded.  
2.1.5 Aldosterone treatment  
Aldosterone treatment was administered to HUVECs to investigate the effect on ENaC 
expression and EC morphology. A concentrated 100 µM stock of aldosterone (Sigma-Aldrich 
Germany Cat# A9477-5MG) was made up, which was further diluted down to a concentration 
of 10nM using EBM-2 endothelial medium. This medium was then used for HUVECs only and 
not for HAECs.  
2.1.6 Amiloride treatment  
Amiloride treatment was administered to HUVECs to investigate the effect on ENaC expression 
and EC morphology. A concentrated 5 mM stock of amiloride (Sigma-Aldrich Germany Cat# 
A7410-1G) was made up, which was further diluted down to a concentration of 10 µM using 
EBM-2 endothelial medium. This medium was then used for HUVECs only. 
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2.2 Immunofluorescence  
Immunofluorescence was used to confirm the presence of the plate endothelial cell adhesion 
molecule CD31, an endothelial specific marker. This carried out on both HAECs and HUVECs 
to confirm the cells to be off endothelial origin and not fibroblast.  
2.2.1. Fixation 
ECs within the ibidi chambers (0.6 luer slides) were washed with PBS solution (made up using 
PBS tablets and distilled water) (Sigma-Aldrich, Darmstadt, Germany Cat# P4417) twice 
before being fixed with 4% paraformaldehyde (Sigma-Aldrich, Darmstadt, Germany Cat# 
P6148) in PBS pH 7.4 for 10 mins at room temperature. Following the incubation, ECs were 
washed with ice cold PBS solution for 5 mins, three times.  
2.2.2. Permeabilization  
Following the fixation step, ECs were permeabilized due to the target protein CD31 being 
located in the intracellular domain. To permeabilized the ECs, a PBS solution containing 0.25% 
Triton X-100 (Sigma-Aldrich, Darmstadt, Germany Cat# 11332481001) was applied to the 
ibidi chambers and incubated for 10mins at room temperature. ECs were then rinsed using PBS 
solution for 5mins, three times.  
2.2.3. Blocking and immunostaining 
ECs were incubated in a blocking solution made up of 5% goat serum (Sigma-Aldrich, 
Darmstadt, Germany Cat# G9023) for 30 mins. Following the removal of the blocking solution, 
the ECs were incubated in the primary antibody of CD31/PECAM-1 (Thermofisher, Rockford, 
USA Cat No. MA5-16337) at a concentration of 1:50 at 4°C overnight. Following the 
incubation, ECs were washed with PBS solution three times. Following the removal of the 
primary antibody, a secondary antibody Goat anti-Rabbit IgG (H+L) Cross-Absorbed, Alexa 
Fluor 546 (ThermoFisher, RockFord, USA Cat# A-11010) was applied at a concentration of 
1:200. The ECs were incubated for 1hr at room temperature and then washed with PBS solution 
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three times. A negative control of secondary antibody only was applied on ECs to test for non-
specific binding.  
2.2.4 Mounting of ECs 
After the immunostaining, ECs were mounted with anti-fade mounting medium 
(VECTASHIELD, Vector Laboratories, California, USA Cat # H-1200) with DAPI staining 
and stored at 4°C protected from light.  
2.2.5 Confocal microscopy  
The immunofluorescences images of DAPI and CD31staining in ECs were obtained with a 
Nikon A1+ inverted confocal laser scanning microscope (Nikon® Instruments Inc., Tokyo, 
Japan) with 450 nm (HV: 157, Offset: -26, Laser: 3.4) diode laser for DAPI and 561 nm (HV: 
93, Offset: 0, Laser: 3.4) diode laser for CD31. The ECs were imaged using a 40x objective, 
taking images every 16.6 µm. All images were analysed using Image J software.  
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2.3 Growing cells under shear stress 
ECs were grown under shear stress (SS) using a commercially available cell culture perfusion 
system (ibidi, Munich, Germany). This system is designed to replicate a more in-vivo 
environment due to the exposure of the cells to SS. ECs in the ibidi system can be exposed to 
specific levels of shear stress ranging from 1.9 to 17.9 dyns/cm2, which is similar to what ECs 
are exposed to within the blood vessels (Davies et al., 2005). 
 
Figure 1. Schematic diagram showing ibidi setup. A) Computer, B) Pump, C) Medium reservoirs, D) Fluidic unit, E) 
Ibidi flow chamber that contains the ECs. Image adapted from Ibidi manufacture manual.  
The system consists of multiple parts (Figure 1). The ibidi pump and ibidi fluidic unit work 
together to create a flow of EBM-2 medium within the ibidi flow chambers (Figure. 1E). The 
pump (Figure. 1B), the medium moves from one reservoir to the other reservoir (Figure. 1C), 
through the flow chamber (Figure. 1E). The pump generates a static pressure (mbar) that results 
in a specific flow rate (ml/min), which produces a laminar shear stress (dyns/cm2). The flow 
rate is dependent on the pressure input, the viscosity of the medium, and the flow resistance of 
the perfusion system (tubing and slide). Since viscosity and tubing resistance do not change, 
changes in the pump pressure are used to change the shear stress (5 and 10 dyns/cm2). The flow 
chambers that were used for this project were the ibidi treat, µ-slide I 0.6 Leur (flow chamber) 
slides (ibidi, Munich, Germany Cat# 80186). These chambers came pre-coated with a special 
coating of Collagen IV solution. This coating provides optimal growth conditions for cell 
cultivation.  
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2.3.1 Preparation of cell culture perfusion system materials.  
All of the materials including, the flow chambers, media, tubing (including the perfusion set) 
had to be equilibrated overnight inside the incubator in 20% O2 and 5% CO2 at 37°C. This 
procedure was an essential step to avoid the generation of air bubbles in the circulating medium, 
which is detrimental to ECs. 
2.3.2 Seeding the HUVECs and HAECs into the flow chambers 
When the ECs (HUVECs or HAECs) were confluent in T-25 flasks of ~80-90%, ECs were sub-
cultured as mentioned in section 2.1.4. The only difference in this protocol was that a cell 
concentration of 1.6 x 106 cells/mL was prepared in a total volume of 150 µL following the 
pellet formation. This subculture was carried out under a sterile cell culture hood. The cell 
suspension of 150 µL was pipetted into the ibidi chambers and incubated (20% O2 and 5% CO2 
at 37°C) for 30mins to allow for cell attachment (Optimised protocol from Ibidi protocol, 
Appendix 1). 
After the 30 mins, the flow chambers were filled using a pipette, with 100µL of EBM-2 medium 
and incubated for a 24 hrs to allow cells to form a confluent layer. An important note for this 
protocol was that it had to be carried out under a 15 min time frame, in order to prevent the 
cells from any additional stresses. ECs can become agitated and stressed under the slightest 
disturbance, which can lead to cell death and detachment. ECs were incubated for 48 hrs and 
underwent a change in medium every day until ready for experiments, usually by the end of 48 
hrs.  
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2.3.3 Experiment parameters for perfusion system 
After the 48 hrs incubation, the ibidi chambers were connected to the fluidic unit. This work 
was carried out under a sterile cell culture hood. It is important to note that the connection had 
to be carried out under a 15 min time frame, in order to prevent the cells from any additional 
stresses. ECs can become agitated and stressed under the slightest disturbance, which can lead 
to cell death and detachment. Once the flow chamber was connected to the fluidic unit, the 
system was placed inside the incubator where it was connected to the pump (air pressure tubing 
and electrical cables). The flow was switched on once the set up was inside the incubator using 
the laptop which had the controlling software (PumpControl). The flow parameters were 
different for HUVECs and HAECs and the table below highlight the differences (Table. 1 & 2) 
for the flow experiment including the shear stress conditions.  
Table 1. Ibidi flow experiment parameters used for shear stress conditions in 0.6 flow chambers for 
HUVECs. To obtain these parameters a fluidic red perfusion set was selected (length 15cm, internal diameter 
1.6mm) 
Experiment Pressure  Shear Stress  Flow rate  Time span 
1 15.8 mbar 5 dyns/cm2 8.32 ml/min 24 hrs 
2 33.9 mbar 10 dyns/cm2 16.64 ml/min 24 hrs 
 
Table 2. Ibidi flow experiment parameters used for shear stress conditions in 0.6 flow chambers for HAECs. 
To obtain these parameters a fluidic yellow/green perfusion set was selected (length 50 cm, internal diameter 1.6 
mm) 
Experiment Pressure  Shear Stress  Flow rate  Time span 
1 48.2 mbar 10 dyns/cm2 16.64 ml/min 24 hrs 
2 82.0 mbar 15 dyns/cm2 24.96 ml/min 24 hrs 
 
  
 2. Material and Methods 
26 
The parameters of the Ibidi system under which the flow experiments were based on the 
following formula derived from manufacturer protocol (ibidi, Germany) (Equation. 2) 
Equation 2. Shear stress in the µ-Slide I Luer family, for the µ-Slide I 0.6 Luer used for the experiments  
τ = η ∙ 60.1 ∙ Φ 
 = shear stress dyns/cm²  
 = dynamical viscosity dyns/cm² 
60.1 = constant factor relative to the 0.6 ibidi chamber  
 = flow rate ml/min  
2.4 Morphology analyses 
ECs were visualised to examine the morphological appearance. Images of ECs either in cell 
culture petri dishes or ibidi chambers were taken using the Infinity 3 camera (Lumenera, 
Ottawa, Canada) attached to a microscope (Olympus CK41, Olympus Scientific solutions, 
USA) at 10x magnification. To assess the changes in endothelial morphology a series of 
analyses were undertaken. Analyses of the ECs images were conducted using Image J, 
including EC angle in relation to the flow direction, EC elongation ratio and endothelial whole 
cell area in relation to the flow direction.  
2.4.1 Endothelial cell angle quantification to the direction of flow.  
The protocol to analyse the EC alignment to the direction of flow was optimised with the 
assistance of Andrew McNaughton from Otago Electron Microscope. To evaluate changes in 
EC orientation in response to flow a method of analyses was created using Fiji (Icy software 
plugin) and Image J software (Windows Version) for images taken before and after the SS 
experiments. The images of HUVECs and HAECs were analysed to quantity the angles of the 
ECs with respect to direction of flow.  
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To measure if and how SS affected the cell alignment, the cell angle with regards to the direction 
of flow was determined before and after the exposure of SS over a 24 hour period. For 
quantification the number of cells (given as percentage of cells) grown in a certain angle was 
counted. The cell alignment was segregated into 10 representative bin angles with a width of 
18 degrees for each bin (eg. Bin 1: 90, Bin 2: 72, bin 3: 54 and so on). For this analyses, Image 
J was used to quantify the angle of the cell. For the ECs to be considered as nicely aligned to 
the direction of flow, cells must be aligned to 0° and partially aligned cells were indicated to be 
in -18 and 18° angle bins. 
 
Figure 2. Analyses of the EC alignment to flow via quantification of the EC angles before and after application of 
SS. A) Images taken before and after SS experiments under 10x magnification. B) Images placed into ICY 
software to remove background and colourisation. Orientation of the cell was outlined with a white border. C) 
Following the ICY step, images placed into Fiji software and were threshold to highlight the outline of the ECs. 
D) Once threshold the photomicrograph was analysed using Directionality under which the outline of the EC 
was analysed to provide an angle for the cell. Image above depicts the green line to show how the angle for the 
EC was measure based on the orientation. Images hand drawn using Biorender software ®  
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2.4.2 Endothelial elongation ratio and area in respect to flow 
To assess the elongation ratio of the ECs cultured within the ibidi perfusion system under 0, 5 
and 10 dyns/cm2, a random selection of 30 ECs per image, (3 images per experiment) were 
outlined using a Wacom tablet. From these cells the whole cell are and the long and short axis 
was measured. The elongation ratio was calculated by dividing the long axis to the short axis. 
A ratio greater than 2 demonstrated endothelial elongation (Figure 3C). A ratio close to 2 




Elongation ratio = long axis / short axis 
Figure 3. Analyses of EC morphology for elongation ratio using short and long axis of the cell with a different 
morphology. A) EC under no SS, B) EC depicting a rounded cell morphology after SS. C) EC depicting a elongated cell 
morphology in response to SS. Images adapted from Biorender © 
 
2.4.3 Statistical analyses for morphology  
All angle and morphology data were statistically analysed with GraphPad Prism Software. For 
the statistical analyses, a two-way ANOVA and a multiple comparisons statistical analyses was 
performed for angle alignment data. All whole cell area data and EC elongation ratio data was 
analysed using a one-way ANOVA and multiple student t-tests. Data were presented as mean 
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2.5. Molecular biology 
A molecular biological approach was used to investigate the expression of ENaC in the 
HUVECs and human vessels (saphenous veins and mammary arteries).  
2.5.1 Primers  
Primers were obtained for the specific ENaC subunits (Sigma-Aldrich, Auckland, New 
Zealand), including α, β, γ, δ and the endogenous control of GAPDH. These primers were 
identified from the gene database from PUBMED (Table. 3). These primers were specific to 
human ENaC and the rodent primers are different. Primers were re-suspended in RNA-free 
water (Qiagen, Venlo, Netherlands) to a given concentration of 10 µM and then aliquoted (10 
µL) and stored at -20 ̊C. Primers aliquots were diluted (1:10) in RNA-free water, for use.  
Table 3 Primers sequences used for the RT q-PCR protocol. Rpresents the gene sequences of both reverse and forward 
primers of ENaC subunits (α ß γ δ) for PCR analyses to detect gene profiles within vessels and cell samples (PUBMED) 
 





Human α ENaC 
Forward 5' GGGTACTGCTACTATAAGCTC 
185bp 




Human β ENaC 
Forward 5' CTGGTCCTTATTGATGAACG 
135bp 




Human γ ENaC 
Forward 5' GCTTTAAAGAGTGGACACTAA 
116bp 




Human δ ENaC 
Forward 5' AHHHGTCTGCATTCAAG 
143bp 





Forward 5' ACAGTTGCCATGTAGACC 
250bp 
Reverse 3' TTTTTGGTTGAGCACAGG 
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2.5.2. Real Time Quantitative Polymerase Chain Reaction (RT q-PCR) for ENaC gene 
expression.  
RT q-PCR was used to analyse the expression of ENaC subunits within the HUVECs and 
HAECs at the messenger RNA level. Amplification of the specific ENaC targets is described 
in the following sections.  
2.5.3. Lysis of ECs.  
After the end of the shear stress exposure in the Ibidi system, the ECs were extracted for RNA, 
in accordance to an adapted ibidi manufacture protocol (Appendix 2). The ibidi flow chambers 
were removed from the cell culture perfusion system within the incubator. The flow chambers 
were imaged for morphology analyses (see section 2.4) and then washed five times with 120 
µL of sterile phosphate buffer saline (PBS).  
ECs were homogenised within the ibidi flow chambers in 200µl of Trizol lysis buffer (Qiagen, 
Venol, Netherland, Cat# 79306) and aspirated via a 1 mL syringe attached to one end of the 
chamber. The cell suspension was then further mixed with 150 µL of Trizol lysis buffer to make 
a total of 350 µL in a 1 mL Eppendorf tube. Finally, the sample was vortexed for 30 secs to 
homogenize the lysate completely. ECs samples were stored at -80°C in the freezer until RNA 
extraction was conducted.  
2.5.4. RNA extraction from ECs 
Homogenates of ECs were thawed for 5mins in a 65̊ C water bath. 40 µL of chloroform was 
added to 200 µL out of 350 µL of the homogenate (the remainder homogenate was frozen as 
the columns had a capacity of 200 µL) and incubated for 5mins at room temperature (Appendix 
2). The homogenate was then centrifuged for 10mins at 16,000 g at 4°C to separate the 
homogenate into two layers, cell debris (pellet) and the aqueous phase which includes the total 
RNA.  
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Approximately 75 µL of the liquid layer was transferred into a clean 1mL Eppendorf tube and 
an equivalent volume of 80% Ethanol (diluted with Gibco Ultrapure Distilled water) was added. 
The solution was then and applied to Qiagen Micro-RNeasy columns and centrifuged (9,000 g, 
27ºC for 5 mins), filtering the aqueous phase to extract the RNA. 700 µL of RW1 buffer 
(washing buffer) (Qiagen - Kit,) was applied to the columns and centrifuged (9,000 g, 27ºC for 
5mins). This allowed for the efficient removal of biomolecules such as carbohydrates, proteins 
and fatty acids. 500 µL of RPE buffer (wash buffer activated with ethanol) was applied to the 
columns following further centrifugation (9,000 g, 27°C for 5 mins). RPE is a mild washing 
buffer that removes any traces of salts within the columns. 500 µL of 80% Ethanol was added 
and centrifugation was applied to dry the columns out. 10 µL of RNA-free water (Qiagen) was 
applied twice (total 20 µL) with a final set of centrifugation steps in order to elute the total RNA 
samples.  
The total RNA concentration of the samples was measured using a microplate reader 
(Thermofischer, New Zealand). Therefore, 2µL aliquots were added to the microplate and the 
absorbance under 260/280 nm was measured, with the ratio calculated. These data provide 
information on the concentration and purity of the total RNA extracted. An exclusion criterion 
was applied for the 260/280 ratio outcome. Any ratio outcomes below 1 was consider 
contaminated with proteins and ratios between 1 - 1.8 was considered pure. RNA samples 
expressing a 260/280 ratio of less than 1 were excluded and discarded. 
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2.5.5 Reverse transcription 
The PrimeScript RT Reagent Kit (Perfect Real Time, Takara Clonetech, Cat. No. RR037A) was 
used for the transcription of total RNA into complementary DNA (cDNA) and performed 
according to the supplier’s manual (Table 4.) 
Table 4. Reverse Transcription protocol 
Reagent Amount 
5 x PrimeScript Buffer 2 µL 
PrimeScript RT Enzyme Mix I 0.5 µL 
Oligo dT Primer (50µM) 0.5 µL 
Random 6 mers (100µM) 0.5 µL 
Total RNA sample *1 
RNase Free H20 *2 
Total reaction mixture 10 µL 
 
The volume of RNA required to give 1 µL of 500 ng was calculated (*1). The remaining 
reagents of the reverse transcription mixture (Table. 4) were added and the volume made up to 
total of 10 µL with the addition of RNAase free water in a ratio or 1:2 (one-part reaction mix 
and two parts water (*2).The reaction mixture which consists of Table. 4 components, were 
incubated for 15 mins at 37  ̊ C (reverse transcription), followed a further 5 secs at 85  ̊ C 
(inactivation of reverse transcriptase with heat treatment) and a final cooling stage of 4  ̊C.  
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2.5.6. RT-qPCR 
The manufacture’s manual (Takara Clonetech) was used to make up the master mixes for the 
PCR as mentioned in Table 5.  
Table 5. RT-qPCR Master Mix for a single reaction, 48 well PCR plate and 96 well PCR plate 
Reagent 1 well 48 wells 96 wells 
SYBR® Premix Ex Taq 
5 µL 45 µL 65 µL 
Forward Primer (10µM) 0.2 µL 1.8 µL 2.6 µL 
Reverse Primer (10µM) 0.2 µL 1.8 µL 2.6 µL 
RT reaction solution (cDNA) *11 µL *9 µL *13 µL 
RNase free water *3.6 µL *32.4 µL *46.8 µL 
Total 10 µL 90 µL 130 µL 
 
As part of the RT-qPCR protocol, a master mix was made up consisting of the ENaC specific 
forward and reverse primers (Table 3.), along with SYBR green dye (Takara Clontech Cat# 
AK9104) (used to emit a signal for amplification of DNA). The mixture also contained RNase 
free water which was calculated for a sample amount of 1 µL.  
Once made, the master mix was load in 9 µL amounts on a 96 well PCR plate (Lab Supply, 
Dunedin, Cat# EPP0030603303). Following the master mix, all samples were loaded in 
triplicates in 1 µL amounts, with a positive control of Human kidney RNA (Clonetech, Takara, 
Japan, Cat no. 636528) and probed for an endogenous control of GAPDH within the samples. 
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Table 6. Cycling parameters for the RT-qPCR reaction  
Stage Cycle Temperature  Time 
1: Initial denaturation step 
1 95 ̊ C 10 secs 
2: PCR reaction 
40 95 ̊ C 5 secs 
60 ̊ C 34 secs 
3: Dissociation stage 
1 95 ̊ C 15 secs 
60 ̊ C 1 mins 
95 ̊ C 15 secs 
 
For the plating of the PCR reactions, 9 µL of master mix and 1 µL of the RT sample was added 
into the wells. The RT- qPCR was performed using a thermocycler (Applied Biosystems), using 
the ibidi recommended cycling parameters outlined in Table 6 (Appendix 2). 
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2.5.7. Analyses of PCR products 
The relative quantification method by Livak et al., (2001) was used to analyse the gene 
expression from the RT-qPCR reactions. The cycle threshold (Ct) values (relative gene 
expression) for each sample was recorded and then quantified using the ΔCt equation. To obtain 
the fold change in the gene expression of ENaC subunits, the ΔCt value was placed into a 
formula as shown in Equation 3. this produced a gene expression relative to the endogenous 
gene. The Ct values were analysed using Microsoft ExcelTM and GraphPad Prism 7. 
Equation 3. Analyses of PCR gene expression, using the ΔCt method. This equation took the Ct value (A) of 
the endogenous control (B). (D) Relative gene expression was calculated to the endogenous gene GAPDH to 
provide the relative expression within ECs after the endogenous was subtracted.  
 
A. Ct = cycle threshold value (Machine fluoresces) 
B. ΔCt = Ct (ENaC target i.e. α or β…) - Ct (endogenous gene: GAPDH) 



















3. Characterisation and quantification of endothelial 
morphology under SS, aldosterone and amiloride.   
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Introduction.  
Endothelial cells (ECs) within arteries and veins display different phenotypes largely thought 
to be influenced by mechanical forces. Shear stress (SS) in particular, is found to be in two 
different flow patterns i.e. laminar and oscillatory. One of the objectives for this project was to 
investigate the effect of SS on endothelial cell morphology. Two human endothelial cell lines 
were selected for this project, human aortic endothelial cells (HAEC) and human umbilical vein 
endothelial cells (HUVECs). Both types ECs were exposed to two different SS conditions, 
laminar (LSS) and oscillatory (OSS). All the SS experiments were conducted using a cell 
culture perfusion system (Ibidi ©, Germany).  
The first aspect of the project was the optimisations of SS conditions for HAECs and HUVECs. 
Both cell lines have different SS magnitudes within their in-vivo environments; therefore, 
required establishment. For the HUVECs, SS conditions had already been optimized from prior 
projects from the Fronius Lab. However, HUVECs were treated with amiloride and aldosterone 
which required establishment of the protocol for treatments. The purpose of treating HUVECs 
with aldosterone and amiloride was to investigate the effect on HUVEC morphology but also 
on the gene expression of the endothelium sodium channel (ENaC, Chapter 4). 
To establish and confirm the endothelial cells were in fact of endothelial origin, 
immunofluorescence was used to detect the expression of CD31. Within ECs, CD31, also 
known as a platelet endothelial cell adhesion molecule-1 (PECAM-1) is expressed within the 
intracellular membrane. Both HAECs and HUVECs were cultured in Ibidi slides under no SS 
for 24 hrs before being fixed and stained using CD31 specific antibodies. Staining for CD31 
was detected via fluoresce of red and the staining of the nucleus (DAPI) was detected via 
fluoresce of blue.  
The detection of CD31 was confirmed in both HAECS and HUVECs (Figures 4A & B) with 
the vivid red fluoresce at the endothelial membrane. To confirm this was specific binding of 
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the antibody, a negative control consisting of the secondary antibody (Goat anti-Rabbit IgG 
(H+L) Cross-Absorbed, Alexa Fluor 546, Sigma Aldrich) was used on the ECs demonstrating 
no fluoresce when observed under the microscope.  
 
Following the detection of CD31, HAECs and HUVECs were exposed and optimised under SS 
conditions. ECs were exposed to SS conditions respective to their physiological environment. 
All SS experiments were conducted using the cell culture perfusion system and endothelial 
basal medium for both HAECs and HUVECs.  
  
 
Figure 4. Representative images of CD31 endothelial marker taken with inverted confocal microscope at 40x 
objective. HAECs (A) and HUVECs (B) exposed to 0 dyns/cm2 were stained to detect CD31 endothelial marker (red) and 
the nucleus stained with DAPI (blue). Vivid red and blue fluorescence was detected in both cell lines to be of endothelial 
origin. Negative control consisted of secondary antibody only to control for non-specific binding, HAECs (C) HUVECs 
(D). Images presented as n=4, of HUVECs and HAECs staining under no SS.  
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3.1 HAECs under SS optimisation.  
The HAECs were cultured under SS conditions of 0, 5, 10 and 15 dyns/cm2. The application of 
higher SS conditions (>15 dyns/cm2) was not possible due to the limitations of the perfusion 
set in combination with the used perfusion chamber. From the four SS conditions mentioned 
earlier, 10 and 15 dyns/cm2 represent physiological ranges of SS and <10 dyns/cm2 represent 
pathophysiological conditions. All four SS conditions were tested under LSS and OSS for a 
period of 24hours. Images were taken of ECs, after 24 hrs of SS exposure (Figure 5) and any 
effect on cell culture is considered to an effect of SS.  
The HAECs exposed to 5, 10 and 15 dyns/cm2 LSS, over 24 hours revealed the cells to be 
sparsely spread (Figure 5B, 5C & 5D). However, HAECs under no SS (0 dyns/cm2) maintained 
a confluent monolayer, where the HAECs maintained a tight endothelial layer. 
For experiments that used SS pattern of OSS, the HAECs exposed to 5 dyns/cm2 OSS (Figure 
5F n=3 ) were still sparsely spread; however HAECs under 10 and 15 dyns/cm2 (Figure 5G & 
5H n=3) maintained a confluent layer, as observed by a tight endothelial layer across the 
chamber. Based on these optimization steps, SS conditions of 10 and 15 dyns/cm2 were selected 
as the SS magnitude of 5 dyns/cm2 was detrimental to the cell culture. It was also indicated that 
the HAECs favour an OSS pattern in comparison to LSS (quantified later) as the cell culture is 
observed to be maintained under OSS pattern. 
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Figure 5. Representative images of HAEC exposed to various LSS and OSS conditions during optimization of 
perfusion protocol at 10x objective. The effect of different levels of SS on HAECs in terms of sustainability and confluency 
were assessed; 0 dyns/cm2 post LSS and OSS (A & E) had no effect on HAECs, with observations finding monolayer and 
confluent culture. Post 5 dyns LSS and OSS (B & F), HAECs were disrupted and impaired in proliferation. Post 10 and 15 
dyns/cm2 LSS (C & D), HAECs were disrupted; however post 10 and 15 dyns/cm2 OSS (G & H), confluent monolayer and 
culture was observed n=3 of flow experiments.  
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3.1.1 HAEC morphology changes under SS.  
To analyse the effect of SS on endothelial cell morphology, a series of quantifications were 
carried out to measure the change in cell alignment (angle, with respect to the direction of 
applied SS i.e. flow), cell elongation (ratio of endothelial long and short axis) and cell area. All 
three parameters were used to provide an understanding to the morphological changes that 
occur to HAECs under 0, 10, and 15 dyns/cm2 LSS and OSS.   
3.1.2 HAEC do not align correspond to the direction of flow when exposed to LSS.  
To measure if and how SS affected the cell alignment, the cell angle with regards to the direction 
of flow was determined before and after the exposure of SS over a 24 hr period. For 
quantification, the number of cells (given as percentage of cells) grown in a certain angle was 
counted. The cell alignment was segregated into 10 representative bin angles with a width of 
18 degrees for each bin (e.g. Bin 1: 90, Bin 2: 72, bin 3: 54 and so on). For this analyses, Image 
J was used to quantify the angle of the cell. For the HAECs to be considered as well aligned to 
the direction of flow, cells must be aligned to 0° and partially aligned cells were indicated to be 
in -18 and 18° angle bins.  
The cell alignment of HAECs at 0 dyns/cm2 was determined at the beginning of the experiment 
and after 24 hrs (no flow, Figure 6A). HAEC across the quantified bins was found to be in 
sinusoidal orientation and this pattern was unchanged after 24 hours. Indicating that the cell 
alignment of the HAECs did not change within the 24 hr period.  
For HAECs exposed to 10 and 15 dyns/cm2 LSS, ECs did not align to the direction of flow 
(Figure 6B & 6C). For the 10dyns/cm2 experiments, quantification of cell angles depicted a 
change in the number of cells within each of the 10 angle bins (Figure 6B). A shift in the 
percentage of cells from sinusoidal distribution to a wide distribution can be observed in the 
quantification of the HAECs, however this is not statistically significant. As mentioned above, 
the culture confluency and sustainability could contribute to the observed alignment.  
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For the 15dyns/cm2 experiments, the percentage of cells decreased under the angle alignment 
of -36° (Figure 6C, from 13.6% ± 0.56 to 9.9% ± 0.735 p<0.05, n=3) after 24 hours of LSS. 
But the percentage of cells did not increase after 24 hours of LSS within the -18 to 18° angle 
range, which demonstrated no alignment to the direction of flow.  
 
 
Figure 6. HAEC do not align with the direction of flow in response to LSS after 24hrs. (A) 0 dyns/cm2, (B) 10 dyns/cm2 
and (C) 15 dyns/cm2. Data presented percentage of cells under 10 different angle bins. Negative angles represent a measure 
of cell orientation going centre down and a positive angle value represents orientation measured centre up. HAECs before 
LSS align in a sinusoidal manner and after 24 hours of LSS (B&C), orientate into an alignment opposite to that of the 
direction of flow. For C, the percentage of cells decreased under the angle alignment of -36° from 13.6 to 9.9 ± 0.735. Date 
presented as Mean ± SEM *p<0.05 n=3 replicates of experiments (white arrow = direction of flow). Statistical analyses, 
Multiple t-tests. 
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3.1.3 HAEC alignment to the direction of flow when exposed to OSS.  
HAECs exposed to 10 and 15 dyns/cm2 OSS, did not align to the direction of flow (Figure 7B 
& 7C). For the HAECs exposed to 10 dyns/cm2, were found to have a sinusoidal alignment 
exhibited in the quantified data (Figure 7B). For HAECs under 15dyns/cm2 experiments, the 
percentage of cells decreased under the angle alignment of -54° (Figure 7C, from 17.3 ± 2.10% 
to 11.5 ± 2.53% p<0.05, n=3) after 24 hours of OSS. But the percentage of cells did not increase 
after 24 hours of OSS within the -18 to 18° angle range, which demonstrated no alignment to 
the direction of flow. A visual observation made for the HAECs under OSS was the cell 
orientation mimicked the flow pattern and visually under OSS the HAECs were undergoing 
some form of proliferation (not quantified).  
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Figure 7. HAEC do not align with the direction of flow in response to OSS after 24hrs. (A) 0 dyns/cm2, (B) 10 dyns/cm2 
and (C) 15 dyns/cm2. Data presented percentage of cells under 10 different angle bins. Negative angles represent a measure 
of cell orientation going centre down and a positive angle value represents orientation measured centre up. HAECs before 
OSS align in a sinusoidal manner and after 24 hours of LSS (B&C), orientate into an alignment opposite to that of the 
direction of flow. (C), the percentage of cells decreased under the angle alignment of -54° from 17.3% to 11.5% ± 2.53 
Date presented as Mean ± SEM *p<0.05 n=3 replicates of flow experiments (white arrow = direction of flow) Statistical 
analyses, Multiple t-tests. 
 
Overall, it can be observed that the HAECs respond well to the flow pattern when under OSS 
for 24hrs in comparison to the HAECs that were exposed to the LSS conditions (not quantified 
but visually assumed). This would be backed by the fact, anatomically and physiologically the 
HAECs are exposed to various SS patterns at different regions of the aortic tree and 
proportionally would be exposed to more OSS like environments. The following quantification 
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of HAEC morphology should provide a better picture of the HAECs response towards the 
different SS that were exposed.  
3.1.4 HAEC morphology is affected by SS 
HAEC morphology was further assessed by determining the elongation of the cell and the size 
of cell. The elongation of the cell was determined by using a ratio in which single cells where 
traced from images taken before and after SS experiments. Each tracing was analyzed with 
Image J software which provided a set of information per cell. For each EC, a measurement of 
the cells long axis (length), short axis (width) and cell area was obtained. This was done in the 
absence of SS and compared with the values determined after the exposure to SS. 
3.1.4.1 HAECs exhibit an elongated morphology under OSS and a rounded morphology 
under LSS  
For the elongation ratio, the long and short axis measurements were divided (long axis/short 
axis) to provide the elongation ratio. The long axis depicted the distance from one end of the 
cell to the other and the short axis depicted the width at the widest points possible. A ratio of 2 
or less depicted an EC that was not elongated. A ratio of more than 2 depicted an EC that was 
elongated. 
Under 0 dyns/cm2, the HAEC elongation ratio was 3.1 ± 0.12 (Figure 8A) (n=30 cells, N=3 
experiments), indicating the cells were already elongated. After the exposure of 10 dyns/cm2 
LSS, the elongation ratio was 1.9 ± 0.36 (n=30 cells, N=3 experiments), and after 15 dyns/cm2 
LSS, the elongation ratio was 2 ± 0.15 (n=30 cells, N=3 experiments), indicating the cells were 
not elongated and rounder in comparison to 0 dyns/cm2 (Figure 8A, 0 dyns/cm2 3.1 ± 0.12 
p=0.05, n=30 cells, N=3). This indicates that for HAECs exposed to 10 and 15 dyns/cm2 LSS 
became more round which was not expected. No difference was seen between 10 and 15 
dyns/cm2 LSS elongation.  
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Under OSS 0 dyns/cm2, the HAEC elongation ratio was 3.0 ± 0.12 (n=30 cells, N=3 
experiments), (Figure 8B). After the exposure of 10 dyns/cm2, the elongation ratio was 2.9 ± 
0.36 and after 15 dyns/cm2, the elongation ratio was 3.4 ± 0.15 (n=30 cells, N=3 experiments), 
indicating the cells are not different to 0 dyns/cm2 (Figure 8B, p=0.7, n=30 cells, N=3 
experiments). No difference was seen between 10 and 15 dyns/cm2 OSS elongation (p>0.05). 
When the elongation ratio for HAECs exposed to LSS and OSS was compared together, HAECs 
exposed to 10 and 15 dyns/cm2 OSS were significantly elongated in comparison to 10 and 15 
dyns/cm2 LSS (Figure 8C, 10 dyns/cm2 1.9 ± 0.36, 15 dyns/cm2 LSS, 2 ± 0.15 vs 10 dyns/cm2 
2.9 ± 0.36, p=0.05 and 15 dyns/cm2 3.4 ± 0.15, p=0.0008, n=30 cells, N=3 experiments).  
These results show that HAECs are responsive under the OSS conditions, with the highest shear 
rate. It is important to note the HAECs have been exposed to the SS conditions for 24 hrs. None 
of the HAECs have been exposed to one condition and then another. All experiments represent 
one condition only.  
The LSS experiments have already been observed to disrupt the cell layer as shown in the 
photomicrographs (Figure 6). The elongation ratio has  revealed that LSS reduces the HAECs 
already elongated morphology into a rounder morphology, hence the significance noted in 
Figure 8A. This demonstrates the concept that the HAECs retract from a confluent layer under 
LSS, weakening the endothelium layer and enabling dysfunction to occur (speculation). 
However, to see if the change in elongation under the different SS conditions also effects the 
area, the area for HAECs also was quantified to note the overall effect of SS on the HAECs 
morphology and the detriment of the LSS.  
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Figure 8. HAECs exposed to OSS elongated in comparison to LSS conditions. Quantification of the long/short axis ratio 
illustratiting the elongation of HAEC under SS conditions, (A) LSS 0, 10 and 15 dyns/cm2, HAECs under 10 and 15dyns/cm2 
have rounded cell morphology in comparison to 0 dyns/cm2 which is elongated. (B) OSS 0, 10 and 15 dyns/cm2, HAECs 
under 10 and 15 dyns/cm2 had elongation ratios of greater than 2, indicating cells are elongated but are not statistically 
significant when compared within OSS (C) LSS vs OSS, HAECs exposed to 10 and 15 dyns/cm2 OSS were significantly 
elongated in comparison to 10 and 15 dyns/cm2 LSS. Data presented as Mean ± SEM *p<0.05, ***p<0.0008 (n=30 cells, 
N=3 experiments for each condition). Statistical analyses, 2-way ANOVA (A & B), Multiple t-tests (C). 
 
3.1.4.2 HAECs cell area was reduced under OSS  
For the cell area quantification, photomicrographs of HAECs after 24 hrs of SS were analysed 
using Image J software. Under 0 dyns/cm2, the HAEC cell area was 2480.26 ± 358.3µm2 (LSS) 
(Figure 9A) (n=30 cells, N=3 experiments). After the exposure of 10 dyns/cm2 LSS, the cell 
area was 1733.96 ± 591.2µm2 and after 15 dyns/cm2 LSS, the cell area was 1090.9 ± 72.2µm2 
(n=30 cells, N=3 experiments), this indicated no change occurred to the HAEC cell area when 
exposed to LSS. 
Under 0 dyns/cm2, the HAEC cell area was 2480 ± 358.4µm2 (OSS) (Figure 9B) (n=30 cells, 
N=3 experiments). After the exposure of 10 dyns/cm2 OSS, the cell area was 378.5 ± 35.6µm2, 
indicating HAEC cell area is contracted under 10 dyns/cm2 in comparison to 0 dyns/cm2 (Figure 
9B, p= 0.006). After the exposure of 15 dyns/cm2 OSS, the cell area was 2143.72 ± 899.9µm2 
(n=30 cells, N=3 experiments), indicating no change in the cell area (Figure 9B). When the cell 
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area for HAECs exposed to LSS and OSS was compared together, no statistical difference was 
noted (n=30 cells, N=3 experiments) (Figure 9C).  
 
 
Figure 9. HAECs under LSS and OSS does not alter the cell area. Quantification of the cell area under SS conditions, 
(A) LSS 0, 10 and 15 dyns/cm2 (B) OSS 0, 10 and 15 dyns/cm2 (C) LSS vs OSS. HAEC cell area is contracted under 10 
dyns/cm2 in comparison to 0 dyns/cm2. When the cell area for HAECs exposed to LSS and OSS was compared together, no 
statistical difference was noted. Data presented as Mean ± SEM **p<0.005, (n=30 cells, N=3 experiments for each 
condition). Statistical analyses, 2-way ANOVA (A & B), Multiple t-tests (C). 
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3.1.5 Summary of findings.  
HAECs were established in this project to gain an understanding of the effects of SS on arterial 
EC morphology. Following the optimization of SS conditions under LSS and OSS flows, 
HAECs have been confirmed to maintain a sustainable culture and confluency under OSS 
conditions in comparison to LSS. Morphology quantifications found HAECs did not align to 
the direction to flow. HAECs exposed to 10 and 15 dyns/cm2 OSS conditions elongated in 
comparison to LSS and the area was contracted under 10 dyns/cm2 OSS.  
These changes witnessed in HAECs post SS conditions confirm that the LSS condition reduces 
the HAEC morphology to a rounded morphology, whereas the HAECs exposed to the OSS 
conditions have been shown to elongate and obtain a reduced cell area to almost compensate 
the elongation. These findings are unique and very preliminary as the establishment of the cell 
line within the flow system was a difficult task.  
These findings overall suggest that the optimal condition for HAECs in this experimental set 
up is OSS in comparison to LSS. Unfortunately, due to time constrains the HAECs were solely 
used to experiment on for different SS conditions under LSS and OSS. In the next chapter, 
ENaC quantification at the gene level was conducted for HAECs as well. It is important to note 
that these ECs were not used for aldosterone and amiloride treatments as the cultivation time 
for HAECs took several weeks which logistically was not fundamental to continue with, based 
on the timeline for this project. The HUVECs were used for the aldosterone and amiloride 
treatments..  
The following sections focused on HUVECs and the treatments of aldosterone and amiloride 
were also conducted on HUVECs.   
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3.2 HUVECs under SS optimisation  
HUVECs were exposed to 0, 5 and 10 dyns/cm2 of SS magnitudes under LSS and OSS which 
represents physiologically relevant SS in the venous system ranges that have been reported to 
range between 5-7 dyns/cm2 (Davies et al., 2005) Cells were perfused with medium for 24 
hours for each SS rate (0, 5 and 10 dyns/cm2) and pattern (LSS, OSS).   
 
Figure 10. Representative images of HUVECs exposed to various LSS and OSS conditions during optimization of 
perfusion protocol at 10x objective. The effect of different levels of SS on HUVECs in terms of sustainability and confluency 
were assessed; 0 dyns/cm2 post LSS and OSS (A & D) had no effect on HUVECs, with observations finding monolayer and 
confluent culture. Post 5 dyns LSS and OSS (B & E), and post 10 LSS and OSS (C & D) confluent monolayer and culture 
was observed n=3 flow experiments.  
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Post LSS and OSS experiments a confluent layer of cells was observed irrespective of SS 
magnitude and pattern. HUVECs under 5 and 10 dyns/cm2 were visually evident to have 
morphological changes in comparison to 0 dyns/cm2 (Figure 10B-F). The magnitude of 10 
dyns/cm2 was selected to replicate abnormal physiology in the case of pathology, but also 
replicates the change in SS venous ECs experience when in the setting of coronary artery bypass 
graft. During which the saphenous vein in humans can be used to replace coronary arteries and 
the vein ECs are exposed to higher SS in comparison to their lower SS environment. 
3.2.1 HUVEC morphology changes under SS.  
To analyse the effect, a series of quantifications were carried out to measure the change in cell 
alignment (angle), cell elongation (long and short axis) and cell area. All three parameters were 
used to provide an understanding to the morphological changes that occur to HUVECs under 
0, 5, and 10 dyns/cm2 LSS and OSS.  
To determine if and how SS affected the cell alignment, the cell angle with regards to the 
direction of flow was determined before and after the exposure of SS over a 24 hr period. For 
quantification, the number of cells (given as percentage of cells) grown in a certain angle was 
counted. The cell alignment was segregated into 10 representative bin angles with a width of 
18 degrees for each bin (eg. Bin 1: 90, Bin 2: 72, bin 3: 54 and so on). For this analyses, Image 
J was used to quantify the angle of the cell. For HUVECs to be considered as well aligned to 
the direction of flow, cells must be aligned to 0° and partially aligned cells were indicated to be 
in -18 and 18° angle bins. This was done for HUVECs under SS and then further treated with 
aldosterone and amiloride.  
3.2.2 HUVECs do align to the direction of flow when exposed to LSS 
HUVECs exposed to 0 dyns/cm2 (no flow) did not change in cell angle alignment. HUVECs 
across the quantified bins remained similar after a period of 24hrs (Figure 11A). HUVECs 
displayed no preferred peak in orientation. For HUVECs exposed to 5 and 10 dyns/cm2 LSS, 
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ECs did align to the direction of flow (Figure 11B & 11C). For the 5 dyns/cm2 experiments, 
visual observations depict a sinusoidal orientation of HUVEC alignment; however 
quantification of cell angles depicted a significant increase in the percentage of cells within 
angle bin of 0° (Figure 11B, 9.6% to 15.1% ± 3.5 p=0.02, n=4). This increase in angle indicates 
HUVECs align to the direction of flow.  
For the 10 dyns/cm2 experiments (Figure 11C), the percentage of cells increased under the angle 
alignment of -18° (9.3% to 12.8 % ± 0.58, p<0.05 n=4) and 0° (9.1% to 13.5 % ± 1.9, p<0.05 
n=4). A decrease in the percentage of cells was seen under the angle alignment, -90 (11.9% to 
8.6 % ± 0.70, p=<0.05 n=4), -72 (11.7% to 8.8 % ± 0.83, p<0.05 n=4) and 72 (10.8% to 7.9 
% ± 0.57, p<0.05 n=4). This confirms a shift in the angle orientation after the exposure of LSS, 
but also the direct influence of flow on HUVECs alignment to the direction of flow after 24 hrs.   
HUVECs in comparison to HAECs respond well the SS and are clearly seen to respond to LSS 
by aligning to the direction of flow, the cells also maintained a confluent layer upon visual 
inspection (not quantified) in comparison to HAECs where the cells became detached.  
The next set of quantification looked at the HUVECs and alignment under OSS and how it 
compared to the cells that were treated with LSS.    




Figure 11. HUVEC do align to the direction of flow, 24hrs after being exposed to LSS (A) 0 dyns/cm2, (B) 5 dyns/cm2 
(C) 10 dyns/cm2. Data presented percentage of cells under 10 different angle bins. Negative angles represent a measure of 
cell orientation going centre down and a positive angle value represents orientation measured centre up. HUVECs before 
LSS align in a sinusoidal manner and after 24 hours of LSS (B&C), orientate into an alignment to the direction of flow. 
Data presented as Mean ± SEM *p<0.05, LSS n= 4 replicates of flow experiments (white arrow = direction of flow) 
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3.2.3 OSS decreases alignment in HUVECs 
HUVECs exposed to 5 and 10 dyns/cm2 OSS, ECs did align to the direction of flow (Figure 
12B & 12C). For the 5 dyns/cm2 experiments, the percentage of cells increased under the angle 
alignment of-18° (9.2% to 11.4% ± 0.63 p<0.05 n=4), 0° (9.6% to 12.9% ± 0.88 p<0.05 n=4) 
and 18° (9.1% to 11.8% ± 0.56 p<0.05 n=4) (Figure 12B). A decrease in the percentage of 
cells seen under the angle alignment of -90° (11.4% to 8.5% ± 0.71 p<0.05 n=4) these changes 
in angles indicate HUVECs align to the direction of flow, despite giving a disrupted 
visualisation (Figure 12C).  
After exposing HUVECs to 10 dyns/cm2, the percentage of cells increased under the angle 
alignment of -36° (9.6% to 13.9 % ± 1.4, p<0.05 n=4), -18° (9.2 to 15.4% ± 1.7 p=0.005 n=4) 
and 0° (9.6% to 13.7 % ± 1.2, p<0.05 n=4) was present (Figure 12C). A decrease in the 
percentage of cells was noted for angles, -90° (11.4% to 7.0% ± 0.87 p<0.05 n=4) and 72° 
(10.6% to 6.4% ± 0.73 p<0.05 n=4) (Figure 12C).This indicates HUVECs under OSS did align 
to the direction of flow but the amount of alignment was decreased in HUVECs.  
Although not statically compared together, visually HUVECs subjected to LSS conditions 
demonstrated an alignment to flow; however HUVECs subjected to OSS conditions 
demonstrated a synodal appearance and the percentage of cells numbers can be distinctly noted 
to be sitting away from the direction of flow (0 degrees) as depicted in Figure 12C. What this 
means overall is that HUVECs demonstrate an adaptable behaviour/nature that basically 
enables these ECs to adapt to the type of SS magnitude and pattern the cells are exposed to for 
a 24 hr period. The following subsections investigated the morphological changes such as 
elongation and changes in areas, HUVECs underwent with SS. 
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Figure 12. HUVEC alignment to the direction of flow, 24hrs after being exposed to OSS (A) 0 dyns/cm2, (B) 5 dyns/cm2 
(C) 10 dyns/cm2. Data presented percentage of cells under 10 different angle bins. Negative angles represent a measure of 
cell orientation going centre down and a positive angle value represents orientation measured centre up. HUVECs before 
OSS align in a sinusoidal manner and after 24 hours of OSS (B&C), orientate in a disrupted alignment to the direction of 
flow; however quantification indicates HUVECs do align to the direction of flow.)Data presented as Mean ± SEM *p<0.05, 
**p<0.001, ***p<0.0001, ****p<0.00001. OSS n=4. Replicates of flow experiments (white arrow = direction of flow). 
Statistical analyses, Multiple t-tests. 
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3.2.4 HUVEC EC morphology is affected by SS 
HUVEC EC morphology was further assessed by determining the elongation of the cell and the 
size of cell area. The elongation of the cell and cell area were calculated using the same method 
used for HAECs (Section 3.2.3).  
3.2.4.1 HUVECs exhibit an elongated morphology under LSS and a rounded morphology 
under OSS  
Under 0 dyns/cm2, the HUVEC elongation ratio was 2.1 ± 0.12 (Figure 13A) (n=30 cells, N=4 
experiments), indicating the cells were elongated. After the exposure of 5 dyns/cm2 LSS, the 
elongation ratio was 2.4 ± 0.27 and after 10 dyns/cm2 LSS, the elongation ratio was 5.9 ± 0.29 
(Figure 13A, n=30 cells, N=4 experiments), indicating the cells were elongated and HUVECs 
exposed to 10 dyns/cm2 LSS were significantly elongated in comparison to 0 and 5 dyns/cm2 
(Figure 13A, 5.9 ± 0.29 vs 2.4 ± 0.27 p<0.05, n= 30 cells, N=4 experiments) which was 
expected. No difference was seen between 0 and 5 dyns/cm2 LSS elongation.  
Under OSS 0 dyns/cm2, the HUVEC elongation ratio was 2.3 ± 0.32 (n=30 cells, N=4 
experiments), indicating the cells are elongated (Figure 13B). After the exposure of 5 dyns/cm2, 
the elongation ratio was 2.9 ± 0.26, indicating the cells were elongated. After 10 dyns/cm2 OSS, 
the elongation ratio was 1.1 ± 0.31 (n=30 cells, N=4 experiments), indicating the cells are 
rounded in morphology in comparison to 0 (Figure 13B, 1.1 ± 0.31 vs 2.3 ± 0.32 p<0.05, n= 
30 cells, N=4 experiments) and 5 dyns/cm2 (Figure 13B, 1.1 ± 0.31 vs 2.9 ± 0.26 p<0.05, n= 
30 cells, N=4 experiments) No difference was seen between 0 and 5 dyns/cm2 OSS elongation.. 
When the elongation data from  LSS  and OSS was compared, the elongation under 10 dyns/cm2 
LSS was significantly reduced under the exposure of 10 dyns/cm2 OSS (Figure 13C, 10 
dyns/cm2 LSS 5.9 ± 0.29, vs 10 dyns/cm2 OSS 1.1 ± 0.31, p<0.01, n=30 cells, N=4 
experiments).  
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These results demonstrated the adaptable ability HUVECs cater to change the cellular 
morphology in response to the environment they are placed into. From the previous section 
(3.2) HUVECs have been noted to align with the direction of flow under LSS. Elongation data 
from quantification has revealed HUVECs elongate in response to LSS, with the higher 
magnitude of LSS. These findings put together would suggest morphology behaviour within a 
venous vessel under physiological conditions. It is noted that the LSS rate is on the cusp of high 
shear stress but in preliminary project like this, these findings are to be considered under 
physiological state.  
For HUVECs exposed to OSS, the previous section (3.2) noted the cells to have a sinusoidal 
appearance and less aligning with the direction of flow. Elongation data suggests the OSS 
reduces the elongation of HUVECs, in particularly under 10 dyns/cm2 which means the ECs 
are not aligning and morphing into cobble like structures as suggested by Figure 13C. For a 
venous vein to exhibit an OSS pattern would be found in regions of bifurcation and curvatures. 
The OSS would also be of lower magnitude such as 5 dyns/cm2 which in this experiment 
suggests HUVECs are elongated (Figure 13C). For higher OSS conditions such as 10 dyns/cm2, 
it would indicate a state of pathology and abnormality and the cells react to the environment by 
retracting the elongation.  
To complete the picture of the changes the HUVECs undergo with the two different SS 
conditions, alignment to the direction of flow and the elongation ratio only make up a proportion 
of the picture. The section ahead investigates quantification of cell area of HUVECs to provide 
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Figure 13. HUVECs elongate under LSS and become rounded under OSS. Quantification of the long/short axis ratio 
illustratiting the elongation of HUVEC under SS conditions, (A) LSS 0, 5 and 10 dyns/cm2 (B) OSS 0, 5 and 10 dyns/cm2 
(C) LSS vs OSS. HUVECs under LSS did elongate significantly post 10 dyns/cm2 (5.946) LSS in comparison to 5 (2.407) 
and 0 (2.135) dyns/cm2 (A) (p=0.00001). HUVECs under OSS did not elongate but became rounded post 10 dyns/cm2 
(1.123) in comparison to 5 (2.919) and 0 (2.230) dyns/cm2 (B). When compared together, the elongation of HUVECs under 
LSS is significantly abolished under OSS (C) (p=0.00004).Data presented as Mean ± SEM **p<0.001, ***p<0.0001 
****p<0.00001 n=30 cells, N=4 experiments (A & B) one-way ANOVA, (C) Multiple t-tests. 
 
3.2.4.2 HUVEC cell area changes under SS  
For 0 dyns/cm2, the HUVEC cell area was 720.7 ± 145.7µm2 (Figure 14A, n=30 cells, N=4 
experiments). After the exposure of 5 dyns/cm2 LSS, the cell area was 940 ± 216µm2 and after 
10 dyns/cm2 LSS, the cell area was 1388 ± 167.5µm2 (n=30 cells, N=4 experiments), an 
increase in cell area was indicated after exposure to 10 dyns/cm2 LSS in comparison to 0 
dyns/cm2 (Figure 14A, 1388 ± 167.5µm2 vs 720.7 ± 145.7µm2 p<0.01, n= 30 cells, N=4 
experiments). No difference was seen between 0 and 5 dyns/cm2 cell area.  
Under 0 dyns/cm2 OSS, the HUVEC cell area was 720 ± 145.7µm2 (Figure 14B) (n=30 cells, 
N=4 experiments). After the exposure of 5 dyns/cm2 OSS, the cell area was 370.9 ± 46µm2 and 
with the exposure of 10 dyns/cm2 OSS, the cell area was 908.9 ± 170.2µm2. A difference in 
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cell area was depicted between 5 and 10 dyns/cm2, where an increase in cell area was indicated 
for HUVECs post 10 dyns/cm2 OSS in comparison to 5 dyns/cm2 (Figure 14B, 908.9 ± 
170.2µm2 vs 370.9 ± 46µm2 p<0.01, n= 30 cells, N=4 experiments). 
When the cell area for HUVECs exposed to LSS and OSS was compared together, cell 
shrinkage was indicated after the exposure of 5 dyns/cm2 OSS in comparison to 5 dyns/cm2 
LSS (Figure 14C, 940 ± 216µm2 to 370.9 ± 46µm2 p<0.05, n=30 cells, N= 4 experiments).  
 
Figure 14. HUVECs cell area under LSS and OSS. Quantification of the cell area under SS conditions, (A) LSS 0, 5 and 
10 dyns/cm2 (B) OSS 0, 5 and 10 dyns/cm2 (C) LSS vs OSS. HUVEC cell area under LSS was increased post 10 dyns/cm2 
in comparison to 5 dyns/cm2 p<0.01 (A) Under OSS, HUVEC area was increased post 10 dyns/cm2 in comparison to 5 
dyns/cm2 p<0.01 (B). When compared together (C), HUVEC cell area under LSS is reduced under OSS post 5 dyns/cm2 
(p<0.05). Data presented as Mean ± SEM *p<0.05, n=4 (A & B) one-way ANOVA, (C) Multiple t-tests 
  
 
In summary, changes in cell area in HUVECs depict a similar trend across the other 
morphological changes seen in 3.2.2 and 3.2.3. With HUVECs exposed to LSS, there is 
alignment seen to the direction of flow and elongation increased after a 24 hr period. This 
section highlights that the area also increases with higher LSS (Figure 14A). When the 
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HUVECs are exposed to OSS, again a similar trend was noted across the other morphological 
changes seen in 3.2.2 and 3.2.3 in which alignment and elongation was reduced. In this section 
the cell area quantified for OSS is shown to be smaller/reduced in comparison to the HUVECs 
exposed to LSS for a 24-hr period.  
Overall, the 3.2 section investigated the effects of SS on HUVEC morphology and the outcome 
from this investigation depicts the understanding that the HUVECs are physiologically under a 
LSS environment. For HUVECs to be exposed to OSS, it would suggest that the cells are 
exposed to a potentially pathological state that reduces and retracts the cell from each other. 
Whether or not these findings for OSS replicate a pathological state in-vivo is difficult to assume 
as the HUVECs have been visually noted to be adaptable to the every so changing SS and flow 
environment. Venous vessels are and have been used as substitutes within cardiac bypass 
procedures which emphasises the ability for these vessels to adapt. For this project, these 
findings provide a baseline for HUVECs behaviour and response to SS. The following sections 
will investigate the effects of aldosterone and amiloride on HUVEC morphology in order to 
understand whether ENaC has a influence on EC morphology. The experiments of aldosterone 
and amiloride on HUVECs were carried out separately as part of the project’s second aim to 
investigate the role of ENaC gene expression in ECs and whether the changes in morphology 
are linked to ENaC expression.  
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3.3. HUVECs treated with aldosterone (10nM) and amiloride (10uM) 
An essential part of the project was to investigate the effect of ENaC within ECs. To do so, 
aldosterone and amiloride were selected as physiological and pharmacological regulators of 
ENaC expression and activity. By using aldosterone and amiloride, the main purpose of these 
experiments was to investigate the effect on endothelial morphology and later ENaC expression 
(Chapter 4). The treatments were separately added into the EBM-2 (endothelial basal medium) 
medium and then applied onto HUVECs with different SS conditions via the cell culture 
perfusion system (ibidi).   
3.3.1 HUVECs treated with aldosterone (10nM) and amiloride (10µM) in FBS -/- medium. 
The initial protocol used for this experiment required for the removal of any potential sources 
of aldosterone and one source included the fetal bovine serum (FBS) which was a component 
of the EBM-2 endothelial medium. Removal of FBS was used to control the exact amount of 
aldosterone being added per experiment. A concentration of 10 nM was used as per 
physiological concentration found in human plasma (Kusche-Vihrog et al., 2008a). The 
removal of FBS (FBS -/-) from the EBM-2 medium caused the HUVECs stress as the ECs, were 
no longer demonstrating confluency and the effects were clearly detrimental (Figure 15A).  
With the exposure of 10 dyns/cm2 LSS, the cell confluency was visually observed to be 
worsened (Figure 4B). With the addition of aldosterone (Figure 15C) and amiloride (Figure 
15E) in FBS -/- free medium was also detrimental under 0 dyns/cm2 (Figure 15C and E) and 10 
dyns/cm2 LSS (Figure 15D and F). Following these observations, FBS was added back into the 
endothelial medium as a reduced confluency and unstainable culture would have produced a 
low cell lysate for gene and protein expression analyses.  
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Figure 15. Representative of HUVECs under different treatment conditions and LSS at 10x objective. Images taken 
24 hrs after HUVECs were to LSS in FBS -/- media at 0 (A) and 10 dyns/cm2 (B). Aldosterone treatment applied in FBS -/- 
media, with LSS of 0 (C) and 10 dyns/cm2 (D). Amiloride treatment applied in FBS -/- media with LSS of 0 (E) and 10 
dyns/cm2 (F). observations can be seen of the HUVECs not surviving and looking unhealthy *Arrows indicate direction of 
flow is left to right n= 3 
 
3.3.2 HUVECs under SS with treatment of aldosterone (10nM) and amiloride (10µM) in 
FBS endothelial media. 
With the FBS supplement added back into the endothelial medium, HUVECs treated with 
aldosterone and amiloride under 5 and 10 dyns/cm2 LSS (Figure 16) demonstrated an 
improvement in cell culture, confluency and survival. For OSS experiments (Figure 17) a 
similar effect was observed with the addition of FBS into endothelium medium. The cells were 
confluent under clear observation. Following this optimisation stage, it was decided for the 
viability of the cells, FBS would remain as part of the endothelium medium.  
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Figure 16. Representative microphotographs of HUVECs under different treatment conditions in FBS media and 
LSS at 10x objective. Images taken 24hrs after HUVECs were exposed to LSS in FBS treated media with Aldosterone 0 
(A), 5 (B), 10 dyns/cm2 (C) and Amiloride 0 (D), 5 (E) and 10 dyns/cm2 (F). With the addition of FBS, cell sustainability 
and confluency immensely improved. Following the application of LSS also found the HUVECs to respond and no 
detrimental effect was observed to that seen in FBS free medium. *Arrows indicate direction of flow is left to right.  
 
 





Figure 17. Representative of HUVECs under different treatment conditions in FBS media and OSS at 10x objective.  
Images taken 24hrs after HUVECs were exposed to OSS in FBS treated media with Aldosterone 0 (A), 5 (B), 10 dyns/cm2 
(C) and Amiloride 0 (D), 5 (E) and 10 dyns/cm2 (F). With the addition of FBS, cell sustainability and confluency immensely 
improved. Following the application of OSS also found the HUVECs to respond and no detrimental effect was observed to 
that seen in FBS free medium. *Direction of flow is left to right. *Arrows indicate direction of flow is left to right 
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3.4. HUVEC morphology under SS with aldosterone 10 nM and amiloride 10 
µM. 
After establishing the HUVECs and analysing the effect of SS on morphology, aldosterone 
treatment was applied to study the effect on ENaC expression but also analyse the effect on 
HUVEC morphology. The effect of aldosterone on the endothelium has been suggested to be 
either direct or indirect. Directly, aldosterone has been implicated in increasing vascular 
oxidative stress, leading to increased vascular resistance (Kusche-Vihrog et al., 2008b). 
Indirectly, angiotensin II leads to the release of aldosterone, which causes endothelial 
dysfunction in turn leading to increase in oxidative stress. Inhibiting the effects of the 
mineralocorticoid receptor, has been successful in reducing the detrimental effects on the 
endothelium.  
To analyse the effect, a series of quantifications were carried out to measure the change in cell 
alignment (angle), cell elongation (long and short axis) and cell area, similar methods used in 
section 3.2. All three parameters (area, elongation and angle) were used to provide an 
understanding to the morphological changes that occur to HUVECs under 0, 5, and 10 dyns/cm2 
LSS and OSS with the treatment of aldosterone. HUVECs were cultured in ibidi chambers 
without any aldosterone and amiloride treatment. Once the cells were confluent and stable, the 
ibidi chamber was then treated with 10 nM of aldosterone or 10 µM of amiloride with the 
exposure of SS for a period of 24 hours.  
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3.4.1. HUVECs treated with aldosterone aligned to the direction of flow under 10 
dyns/cm2 LSS.  
HUVECs exposed to 0 dyns/cm2 did not change in cell angle alignment with the treatment of 
aldosterone (Figure 18A). For HUVECs exposed to 5 dyns/cm2 did not change in cell angle 
alignment with the treatment of aldosterone. Although images taken from the experiment, and 
quantified percentage of cells demonstrate changes in cell angle alignment, the changes were 
not statistically significant (Figure 18B) 
For HUVECs exposed to 10 dyns/cm2, the percentage of cells increased under the angle 
alignment -18° (9.2% to 10.8 % ± 0.38, p<0.05 n=4), 0° (9.6% to 12.1 % ± 0.56, p<0.05 n=4) 
and 18 (8.9% to 12.3 % ± 0.73, p<0.05 n=4). An additional increase was also indicated under 
36° (8.9% to 12.2 % ± 0.59, p<0.05 n=4), and 54° (9.6% to 11.8 % ± 0.58, p<0.05 n=4) 
(Figure 18C).  
A decrease in the percentage of cells was noted under the angle alignment -90 (11.6% to 7.3 
% ± 0.5, p<0.001 n=4), -72 (11.2% to 7.2 % ± 0.48, p<0.0001 n=4) and 72° (10.9% to 9.4 
% ± 0.40, p<0.05). These indicates a direct influence of flow in combination of aldosterone on 
HUVECs alignment to the direction of flow after 24hours (Figure 18C).   
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Figure 18. HUVEC alignment to the direction of flow under LSS with aldosterone. 24hrs after being exposed to LSS 
with aldosterone treatment (A) 0 dyns/cm2, (B) 5 dyns/cm2 (C) 10 dyns/cm2. HUVECs exposed to aldosterone under LSS 
10 dyns/cm2 aligned to the direction of flow (C) as an increase in cells orientated to 0º is significant post laminar experiments 
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3.4.2 HUVECs treated with aldosterone did not align to the direction of flow under OSS 
HUVECs exposed to 0 dyns/cm2 OSS did not change in cell alignment with the treatment of 
aldosterone (Figure 19A) 
For HUVECs exposed to 5 and 10 dyns/cm2 OSS, ECs did not align to the direction of flow 
(Figure 19B & C). For the 5 dyns/cm2 HUVECs did have a decrease an increase in the 
percentage of cells under the angle alignment -90° (11.6% to 15 % ± 0.65, p=0.001 n=4), -72° 
(11.2% to 17.3 % ± 1.7, p=0.01 n=4), and -54° (10.3 % to 14 % ± 1.5, p=0.02) (Figure 19B). 
A decrease in percentage of cells was seen under the angle alignment of -18° (9.2% to 6.9 % 
± 0.5, p<0.0.5 n=4), 18° (8.9% to 6.2 % ± 1.2, p<0.05 n=4), and 54° (9.6% to 6.3 % ± 0.38, 
p<0.05 n=4) (Figure 19B). This indicated cell alignment did not occur to the direction of flow 
under the application of aldosterone and exposure of OSS. This does indicate the cell angles 
did change with the application of aldosterone and exposure of OSS.  
For HUVECs exposed to 10 dyns/cm2 OSS with aldosterone, did not change in cell angle 
alignment with the treatment of aldosterone (Figure 19C). The images taken for these images 
did indicate orientation changes are occurring with the addition of aldosterone and OSS; 
however not statistically significant.  
  




Figure 19. HUVEC alignment to the direction of flow under OSS with aldosterone. 24hrs after being exposed to OSS 
with aldosterone treatment (A) 0 dyns/cm2, (B) 5 dyns/cm2 (C) 10 dyns/cm2. HUVECs exposed to aldosterone under OSS 
5 and 10 dyns/cm2 did not align to the direction of flow (B & C). HUVECs exposed to OSS 5 dyns/cm2 (B) indicated an 
orientation towards ~90-72° (p= 0.001) via the increase in the percentage of cells,, which is not in the direction of flow. 
HUVECs under OSS 10 dyns/cm2 also did not align with the direction of flow as no changes were significant C). Data 
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3.4.3 HUVEC morphology is affected under SS with addition of aldosterone (10nM) 
For the morphology analyses it was hypothesized that with the addition of aldosterone into the 
endothelial media a decrease in elongation ratio will occur due an increase in the cell area size.  
Under LSS 0 dyns/cm2, the HUVEC elongation ratio was 3.4 ± 0.12 (LSS) (Figure 20A, n=30 
cells, N=4 experiments), indicating the cells were elongated. For HUVECs exposed to 5 
dyns/cm2 LSS, the elongation ratio was 3.8 ± 0.27 (Figure 20A, n=30 cells, N=4 experiments) 
suggesting aldosterone with addition of LSS elongated HUVECs. This effect was not see with 
HUVECs under 10 dyns/cm2 and aldosterone treatment. 
For 10 dyns/cm2 LSS, the elongation ratio was 2.1 ± 0.46 (Figure 20A, n=30 cells, N=4 
experiments) were significantly reduced in elongation in comparison to 0 (Figure 20A, 2.1 ± 
0.46 vs 3.4 ± 0.12 p<0.05, n= 30 cells, N=4 experiments) and 5 dyns/cm2 (Figure 20A, 2.1 ± 
0.46 vs 3.8 ± 0.27 p<0.05, n= 30 cells, N=4 experiments) which was expected. No difference 
was seen between 0 and 5 dyns/cm2 LSS elongation which was not excepted.  
Under OSS 0 dyns/cm2, the HUVEC elongation ratio was 3.4 ± 0.32 (Figure 20B n=30 cells, 
N=4 experiments), indicating the cells are elongated. After the exposure of 5 dyns/cm2, the 
elongation ratio was 2.9 ± 0.34. And after 10 dyns/cm2 OSS, the elongation ratio was 2.9 ± 0.31 
(n=30 cells, N=4 experiments), indicating the cells are elongated in morphology in. No 
difference was seen between 0, 5 and 10 dyns/cm2 OSS elongation (Figure 20B) 
When the elongation ratio for HUVECs was compared (LSS vs OSS), the elongation under 10 
dyns/cm2 OSS was significantly increased under the exposure of 10 dyns/cm2 OSS (Figure 
20C, 10 dyns/cm2 LSS 2.1 ± 0.46, vs 10 dyns/cm2 OSS 2.9 ± 0.31, p<0.05, n=30 cells, N=4 
experiments).  
The following section looked into the cell area changes within HUVECs post aldosterone 
treatment and SS.  
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Figure 20. HUVECs elongate under SS with aldosterone. Quantification of the long/short axis ratio illustratiting the 
elongation of HUVEC, (A) LSS 0, 5 & 10 dyns/cm2 (B) OSS 0, 5 & 10 dyns/cm2 (C) LSS vs OSS. HUVECs treated with 
aldosterone 10 nM were significantly reduced in elongation post 10 dyns/cm2 LSS (2.089) in comparison to 5 (3.931) and 
0 (3.403) dyns/cm2 (A) (p=0.05). HUVECs under OSS did not elongate (B). When compared together, HUVECs under OSS 
are significantly elongated post 10 dyns/cm2 with aldosterone, in comparison to LSS (C) (p=0.001). Data presented as Mean 
± SEM *p<0.05**p<0.001, (A & B) one-way ANOVA, (C) Mutiple t-tests n=30 cells, N=4 experiments. 
 
3.4.3.1 HUVEC cell area changes under OSS with the addition of aldosterone  
Under 0 dyns/cm2, the HUVEC cell area with aldosterone 10nM, was 504 ± 62µm2 (LSS) 
(Figure 21A, n=30 cells, N=4 experiments). After the exposure of 5 dyns/cm2 LSS, the cell area 
was 3040 ± 705µm2 and after 10 dyns/cm2 LSS, the cell area was 1589 ± 241µm2 (n=30 cells, 
N=4 experiments).  
Under 0 dyns/cm2 OSS, the HUVEC cell area with aldosterone, was 420 ± 55µm2 (Figure 21B, 
n=30 cells, N=4 experiments). After the exposure of 5 dyns/cm2 OSS, the cell area was 4019 ± 
468µm2 indicating swelling of HUVEC cell area under 5 dyns/cm2 in comparison to 0 dyns/cm2 
(Figure 21B, 4019 ± 468µm2 vs 420 ± 55µm2, p<0.05, n=30 cells, N=4 experiments).  
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After the exposure of 10 dyns/cm2 OSS, the cell area was reduced to 1001.8 ± 75µm (Figure 
21B n=30 cells, N=4 experiments), indicating a cell shrinkage in comparison to 5 dyns/cm2 
(Figure 21B, 1001.8 ± 75µm2 vs 4019 ± 468µm2, p<0.05, n=30 cells, N=4 experiments). 
When the cell area for HUVECs exposed to LSS and OSS was compared together, there was 
no change indicated when the SS pattern from changed from LSS to OSS (Figure 21C)  
 
 
Figure 21. HUVECs cell area under LSS and OSS with aldosterone. Quantification of the cell area under SS conditions, 
(A) LSS 0, 5 & 10 dyns/cm2 (B) OSS 0, 5 & 10 dyns/cm2 (C) LSS vs OSS. HUVECs treated with aldosterone 10nM 
increased in cell area under LSS post 10 dyns/cm2 in comparison to 0 dyns/cm2 (A) (p=0.05). Under OSS, HUVEC area 
was significantly increased post 5 dyns/cm2 in comparison to 0 and 5 dyns/cm2 (B) (p=0.0001). When compared together 
(C), HUVEC cell area under OSS post 5 dyns/cm2 was increased in comparison to LSS (p=0.05). Data presented as Mean 
± SEM , ***p<0.0001 n=4 (A & B) one-way ANOVA, (C) Sidak's multiple comparisons test 
 
In summary, HUVECs treated with aldosterone 10 nM and exposed to SS depicted a range of 
outcomes. It can be stated, that aldosterone induces an effect on HUVEC morphology. Under 
the LSS conditions, the effect of aldosterone was seen to be minimal where the behavioural 
response was similar to that seen in HUVECs under OSS and no aldosterone. HUVECs under 
LSS and aldosterone 10 nM revealed to not fully align to the direction of flow, even with higher 
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magnitudes of LSS. The elongation ratio was seen to be increased under no LSS and 5 
dyns/cm2; however, unlike the non-treated HUVECs, the elongation was not present for the 
cells treated with aldosterone and under 10 dyns/cm2. An interesting observation was made 
when the cell area was quantified, although not statistically significant, HUVECs appear to 
have larger cell area with addition of aldosterone and LSS. Further tests would be required to 
establish a difference.  
When the data is focused onto the HUVECs treated with aldosterone and OSS, the alignment 
is seen to minimal with the orientation of the HUVECs to be random. The elongation ratio 
remains unchanged for HUVECs under the various OSS conditions and the treatment of 
aldosterone. However, the cell areas for HUVECs are reported to have a significant increase 
(Figure 21B p<0.0001) with the addition of aldosterone and 5 dyns/cm2 OSS. However for 
HUVECs under 10 dyns/cm2 OSS and aldosterone, the cell area is reduced in comparison to 5 
dyns/cm2 .  These sets of experiments demonstrate the an effect of aldosterone on HUVECs 
with the addition of SS conditions. What was not expected was the minimal changes under LSS 
and OSS. This is because aldosterone influencing cell volume via water retention and influx, it 
was predicted that there would an increase in cell area with increasing SS conditions. One 
theory that could explain this unexpected results could be that with the application of SS on 
HUVECs, aldosterone was not able to enact on the cells as the concentration used was no 
substantial, the time period was minimal or the effect of the SS experiments washed away the 
aldosterone, preventing it from entering the cells. 
To establish a true effect of aldosterone on HUVECs, chapter 4 will investigate the gene 
expression of ENaC and quantify changes to the expression following treatment. The next 
section however investigated the effects of amiloride an anti-diuretic on HUVECs to see if the 
changes are reduced with addition of SS.  
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3.4.4 HUVECs under SS with the addition of amiloride (10µM)  
Amiloride is a pharmacological drug used as an anti-diuretic (Kleyman et al., 1988). Most 
commonly, amiloride has been used as an antagonist of ENaC, blocking the sodium sensitive 
current. In this project the second objective examines at the effect of amiloride on ENaC 
expression (Chapter 4); however, the other aspect of amiloride effect was to investigate the 
effect on endothelial morphology in particular within HUVECs. Amiloride has been indicated 
to improve endothelial mediated vasodilation and one of the potential mechanisms is via ENaC 
within the endothelium (Martinez-Lemus et al., 2017). Blockade of the channel enables an 
increase in nitric oxide, a potent vasodilator, leading to a reduction in resistance within arteries 
(Martinez-Lemus et al., 2017). The direct effect of amiloride on ECs is fully understood; 
therefore this section focuses on the effect of amiloride on HUVEC morphology with the 
application of LSS and OSS of a period 24 hours. HUVECs were cultured in ibidi chambers 
without any amiloride treatment. Once the cells were confluent and stable, 10µM of amiloride 
was added to the ibidi chamber with the exposure of SS for a period of 24 hours.  
3.4.5 HUVECs treated with amiloride aligned to the direction of flow under LSS.  
HUVECs exposed to 0 dyns/cm2 did not change in cell angle alignment with the treatment of 
amiloride (Figure 22A). However, for HUVECs exposed to the 5 dyns/cm2 there was an 
increase in the percentage of cells under the angle alignment 0° (9.3% to 12.9 % ± 0.75, 
p=0.0002 n=4) and 18° (9% to 15.8 % ± 0.56, p=0.0001 n=4) (Figure 22B). An increase in 
the percentage of cells was seen for the angle alignment of 36° (8.8 % to 16.4 % ± 0.58, 
p=0.0001 n=4) and 54° (9% to 14% ± 1.3, p=0.0001 n=4),  
A decrease in the percentage of cells was seen under angle alignment of -90 ° (12.09 % to 5.39 
% ± 0.59, p<0.05 n=4), -72° (12.2 % to 4.68 % ± 0.62, p<0.05 n=4) and -54° (10.4 % to 4.89 
% ± 0.63, p<0.05 n=4) (Figure 22B).  
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For HUVECs exposed to 10 dyns/cm2 the percentage of cells did not change in angle alignment 
to the direction of flow. The images taken from the experiments did indicate visual 
observations; however not statistically significant.  
 
 
Figure 22. HUVEC alignment to the direction of flow under LSS with amiloride. 24hrs after being exposed to LSS with 
amiloride treatment (A) 0 dyns/cm2, (B) 5 dyns/cm2 (C) 10 dyns/cm2. HUVECs exposed to LSS 5 dyns/cm2 (B) aligned 
significantly towards ~18-54° (p<0.001), which includes the parameters of the direction of flow. HUVECs under LSS 10 
dyns/cm2 did not align with the direction of flow as no changes were significant (C). Data presented as Mean ± SEM, 
***p<0.0001, n=4 Multiple t-tests. 
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3.4.6. HUVECs treated with amiloride did not align to the direction of flow under OSS.  
HUVECs exposed to 0 dyns/cm2 (no flow) OSS did not change in cell alignment with the 
treatment of amiloride (Figure 23A). For HUVECs exposed to 5 dyns/cm2 an increase in the 
percentage of cells was indicated for the angle alignment of -54° (Figure 23B, 10.4% to 14.0 
% ± 1.1, p<0.05).  
For HUVECs exposed to 10 dyns/cm2, a decrease in the percentage of cells was indicated for 
the angle alignment of -54° (Figure 23C, 10.5% to 13.2 % ± 1.1, p<0.002 n=4). This can be 
further confirmed by the reduction in the percentage of cells in the angle alignment of 18° under 
10 dyns/cm2 (Figure 23C, 8.8% to 6.3 % ± 0.6, p<0.05 n=4).  
In summary, HUVECs treated with amiloride show no alignment with flow whether it be under 
LSS or OSS conditions. It can be suggested that with the addition of amiloride the cellular 
response is almost inhibited. Whether this effect come indirectly by blocking ENaC will be 
found out in Chapter 4. For the following section, the elongation ratio is analysed to see whether 
this is also impacted by amiloride.   




Figure 23. HUVECs did not align to the direction of flow under OSS with amiloride. 24hrs after being exposed to OSS 
with amiloride treatment (A) 0 dyns/cm2, (B) 5 dyns/cm2 (C) 10 dyns/cm2. Data presented as Mean ± SEM *p<0.05, 
**p<0.002 n=4 multiple t-tests. 
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3.4.7. HUVEC elongation remains unchanged under SS with the addition of amiloride.  
For this project, it was hypothesized that HUVECs under SS with the application of amiloride 
would present with an elongated morphology. This is based on the pharmacological selectivity 
of amiloride blocking ENaC which regulates salt/water homeostasis. This blockade would 
prevent the movement of electrolytes and water into and out of the cell. 
Under LSS 0 dyns/cm2, the HUVEC elongation ratio was 3.8 ± 0.12 (LSS) (Figure 24A, n=30 
cells, N=4 experiments), indicating the cells were elongated. After the exposure of 5 dyns/cm2 
LSS, the elongation ratio was 3.8 ± 0.27 and after 10 dyns/cm2 LSS, the elongation ratio was 
2.8 ± 0.46 (n=30 cells, N=4 experiments), indicating the cells were elongated. No difference 
was seen between 0, 5 and 10 dyns/cm2 LSS elongation which was not expected as it was 
hypothesized that amiloride would reduce the elongation of HUVECs.  
Under OSS 0 dyns/cm2, the HUVEC elongation ratio was 3.8 ± 0.45 (n=30 cells, N=4 
experiments), indicating the cells are elongated (Figure 24B). After the exposure of 5 dyns/cm2, 
the elongation ratio was 3.2 ± 0.34. And after 10 dyns/cm2 OSS, the elongation ratio was 2.7 ± 
0.31 (n=30 cells, N=4 experiments), indicating the cells are elongated in morphology in. No 
difference was seen between 0, 5 and 10 dyns/cm2 OSS elongation.  
When the elongation ratio for HUVECs was compared (LSS vs OSS), no difference was seen 
when changing the SS patter from LSS to OSS (Figure 24C, n=30 cells, N=4 experiments). 
So in summary, the HUVECs do not change in elongation with the addition of amiloride and 
exposure of SS conditions. This goes in hand with the findings of amiloride and effect on cell 
alignment as seen in the previous section. It can be noted that as a trend, OSS with amiloride 
gives the HUVECs a cobble stone like appearance. Unfortunately, upon statistical comparison 
there are no statistically significant changes noted. So it can be assumed amiloride prevents 
elongation. The following section will investigate the effects on cell area which have been 
predicted to be reduced especially with the function of amiloride being an anti-diuretic.  
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Figure 24. HUVECs quantification for elongation with amiloride. Quantification of the long/short axis ratio illustratiting 
the elongation of HUVEC, (A) LSS 0, 5 & 10 dyns/cm2 (B) OSS 0, 5 & 10 dyns/cm2 (C) LSS vs OSS. HUVECs treated 
with amiloride did not elongate post LSS (A) and post OSS (B) When compared together, no difference was seen in LSS or 
OSS (C) Data presented as Mean ± SEM, n=30 cells, N=4 experiments (A & B) one-way ANOVA, (C) Multiple t-tests  
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3.4.7.1 HUVEC cell area changes under SS with the addition of amiloride (10µM) 
Under 0 dyns/cm2, the HUVEC cell area with amiloride 10µM, was 424 ± 45µm2 (LSS) (Figure 
25A) (n=30 cells, N=4 experiments). After the exposure of 5 dyns/cm2 LSS, the cell area was 
2334.080 ± 436µm2 and after 10 dyns/cm2 LSS, the cell area was 1007.108 ± 38.3µm2 (n=30 
cells, N=4 experiments).  
An increase in cell area was indicated after exposure to 5 dyns/cm2 LSS in comparison to 0 
dyns/cm2 (Figure 25A, 2334.080 ± 436µm2 vs 424 ± 45µm2, p<0.05, n=30 cells, N=4 
experiments).A decrease in cell area was indicated after the exposure to 10 dyns/cm2 LSS in 
comparison to 5 dyns/cm2 (Figure 25A, 1007.108 ± 38.3µm2 vs 2334.080 ± 436µm2, p<0.05, 
n=30 cells, N=4 experiments). No difference was seen between 0 and 10 dyns/cm2 cell area 
(p>0.05). 
Under 0 dyns/cm2 OSS, the HUVEC cell area with amiloride, was 420 ± 45µm2 (Figure 24B, 
n=30 cells, N=4 experiments). After the exposure of 5 dyns/cm2 OSS, the cell area was 804 ± 
232µm2 and after 10 dyns/cm2 OSS, the cell area was 1196 ± 49µm2 (n=30 cells, N=4 
experiments), indicating cell swelling in comparison to 0 dyns/cm2 (Figure 25B, 1196 ± 49µm2 
± 38.3µm vs 420 ± 45µm2, p<0.05, n=30 cells, N=4 experiments). No difference was seen 
between 0 and 5 dyns/cm2 cell area (p=0.3) and between 5 and 10 dyns/cm2 cell area (p>0.05).  
When the SS pattern was changed, cell area was reduced after the exposure of 5 dyns/cm2 OSS 
in comparison to 5 dyns/cm2 LSS (Figure 25C, 2334.080 ± 436µm to 804 ± 232µm2 p=0.05). 
And cell area was increased after the exposure of 10 dyns/cm2 OSS in comparison to 10 
dyns/cm2 LSS (Figure 25C, 1007.108 ± 38.3µm2 to 1196 ± 49µm2 p=0.05, n=30 cells, N=4 
experiments). These findings were not expected as a reduction in cell area was expected 
following the treatment of amiloride, regardless of the SS exposure.  
  




Figure 25. HUVECs cell area under LSS and OSS with amiloride. Quantification of the cell area under SS conditions, 
(A) LSS 0, 5 and 10 dyns/cm2 (B) OSS 0, 5 and 10 dyns/cm2 (C) LSS vs OSS. HUVECs treated with amiloride 10 µM 
increased in cell area under LSS post 5dyns/cm2 in comparison to 0 (p=0.001) 10 dyns/cm2 (p=0.05). (A) Under OSS, 
HUVEC area was increased post 10 dyns/cm2 in comparison to 0 dyns/cm2 (B) (p=0.05). When compared together (C), the 
increase in HUVEC cell area under LSS was abolished under OSS post 5 dyns/cm2 (p=0.05). HUVEC cell area was also 
increased under OSS in comparison to LSS post 10 dyns/cm2 (p=0.05). Data presented as Mean ± SEM *p<0.05, **p<0.001 
n=4 (A & B) one-way ANOVA, (C) Multiple comparisons t-test 
 
In summary, HUVECs treated with amiloride and SS were found to have reduced cell areas. It 
was noted that the OSS conditions had more of a reducing effect on HUVECs with amiloride 
in comparison to the HUVECs under LSS, this was for the SS of 5 dyns/cm2 . An interestingly 
opposite effect was seen for the higher SS conditions, but overall, there is a reducing effect that 
can be concluded from the amiloride experiments. 
So overall, this section demonstrated the effects of amiloride on HUVECs with the exposure of 
SS and no SS. It was predicted the HUVECs morphology would become reduced and appear 
shrunken in comparison to HUVECs with no amiloride treatment. The results have found that 
overall amiloride prevents the HUVECs from undergoing morphology changes in response to 
LSS. The following section will discuss the findings found in Chapter 3. 
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3.5 Discussion 
Endothelial cells (ECs) serve as a barrier and facilitates selective permeability between the 
blood vessel and adjacent tissue (Sakamoto et al., 2010). In vivo, ECs are subjected to various 
mechanical stimuli and demonstrate the ability to adapt in responses via mechanotransduction, 
a process which enables the ECs to convert the mechanical stimuli into a biochemical signal 
regulating a cell response (Flaherty et al., 1972).  
It is widely accepted that vascular ECs when exposed to mechanical stimuli i.e. SS, respond via 
changes within their endothelial morphology (Flaherty et al., 1972; Ookawa et al., 1992; 
Sakamoto et al., 2010). These changes include, elongation and alignment of ECs to the direction 
of flow. Morphology of ECs has been reported to be different amongst the branches of the 
vasculature where the blood flow is either laminar or oscillatory (Baratchi et al., 2019). At sites 
of bifurcations and branching the blood flow is reported to be of turbulent pattern and vessels 
that are straight in anatomy are reported to be of laminar pattern (Ballermann et al., 1998; 
Alenghat & Ingber, 2002). These discrepancies in location within the vascular tress can be 
attributed to the different responses of ECs to various SS magnitudes and patterns reported in 
this project.  
One of the key objectives of this project was to investigate the effects of  SS on EC morphology. 
Endothelial elongation, cytoskeletal realignment and junctional protein relocation have been a 
topic of research and to date is still being investigated within the scientific community. ECs 
within straight vessels elongate and align in the direction of flow and have changes occur in 
junctional proteins. These changes are dependent on the magnitude and pattern of SS (i.e. 
laminar vs oscillatory) (Wechezak et al., 1985). 
Morphology on its own provides a visual observation of the changes that occur to the 
endothelium with the application of a stimulus i.e. SS and treatments. The following sections 
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will break down the results and cover a mechanism which could potentially explain the 
reasoning as to why the ECs reacted in the way to SS and the different treatments.  
It was hypothesized that that following would occur: 
1. Increasing the magnitude of SS will cause ECs angle to align to the direction of flow, 
ECs will be elongated and whole cell area will be increased.  
2. Changing the SS pattern from LSS to OSS will not cause ECs angle to align to the 
direction of flow, ECs will be reduced in elongation and whole cell area will be reduced.  
3. Treating HUVECs with aldosterone will cause ECs angle to not align to the direction of 
flow, EC elongation will be reduced and whole cell area will be increased.  
4. Treating HUVECs with amiloride will cause ECs to align to the direction of flow, ECs 
will be elongated; whole cell area will be reduced.  
Based on the results within this chapter, the main findings have been divided into the 
appropriate cell lines and treatments.  
3.5.1 The effect of SS on HAEC morphology.  
It was hypothesized that the following would occur to HAECs with the exposure of SS: 
1. Increasing the magnitude of SS will cause ECs angle to align to the direction of flow, 
therefore ECs will be elongated and whole cell area will be increased.  
2. Changing the SS pattern from LSS to OSS will not cause ECs angle to align to the 
direction of flow, but ECs will be reduced in elongation and whole cell area will be 
reduced.  
For HAECs exposed to increasing magnitudes of SS, there was no change in cell angle 
alignment to the direction of flow (Figure 6 & 7). HAECs were found to be already elongated 
under no SS. This elongation was reduced when the SS pattern was LSS; however, was restored 
when the SS pattern was changed from LSS to OSS (Figure 8). HAECs had a reduced cell area 
under OSS, which did not change when the SS pattern was changed to LSS (Figure 9).  
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Following the outcome from the experiments, the hypotheses (1 & 2) mentioned above for 
HAECs were not confirmed as the HAECs did not align to the direction of flow. The ECs under 
LSS were reduced in elongation and the cell area did not change. This was opposite to what 
was hypothesized as the changes in HAECs occurred under OSS, where the ECs were elongated 
and reduction in the cell area was noted. These unexpected changes could be explained by the 
fact the pattern under which HAECs are cultivated in an in-vivo environment could correspond 
to an OSS pattern, with an increased SS magnitude. The HAECs are of an aortic origin, which 
means the magnitude of SS is approximately ~ 50 dyns/cm2 (Papaioannou & Stefanadis, 2005). 
This SS is considerably higher in comparison to the 15 dyns/cm2 which is what the HAECs 
were exposed to in this project, although appropriate for the aorta (Ballermann et al., 1998).  
One of the initial observations made during the optimization stage for HAECs was the fact 
HAECs were not surviving and maintaining a confluent monolayer with the application of low 
magnitude SS (between 1-5 dyns/cm2). When the SS was increased to higher magnitude such 
as from 5 to 10 dyns/cm2, the HAECs visually appeared healthier although not proliferating as 
much (Figure 5). The second observation made (not quantified) was the increase in proliferation 
of HAECs when the two SS patterns of LSS and OSS were compared, it was noted that the OSS 
conditions were ideal for the HAECs and proliferation was noted (not quantified). The arterial 
vasculature has a complex structure i.e. bifurcations of the main aorta branching off into small 
arteries and organs for vital blood supply. Due to the several bifurcations the presence of SS is 
likely to be of turbulent and OSS and this can be seen due to the sustainability and confluency 
the ECs maintained when exposed to OSS (Figure 5G & H). 
Previous studies have reported alignment of ECs (HUVECs, Bovine aortic ECs) to the direction 
of flow (Alenghat & Ingber, 2002; Wang et al., 2013), in particular with SS magnitudes of 10 
dyns/cm2 ECs have been reported to induce alignment (Wang et al., 2013). This was not seen 
within this project as HAECs portrayed a more of a perpendicular alignment to the direction of 
flow. A study by Tovar-Lopez and colleagues recently established a similar response from 
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HAEC under OSS where the ECs did not align to the direction of flow and in fact were 
orientated perpendicular to the flow (Tovar et al., 2019). They were also able to establish an 
alignment under LSS for HAECs under 10 dyns/cm2 which is opposite to what was observed 
in this project (Tovar et al., 2019). This indicates Tovar and colleagues were able to maintain a 
HAEC culture under the exposure of SS, 10 dyns/cm2 LSS, which was difficult in this project. 
The difficulties experienced with the HAECs culture could be due to several reasons. The 
number of experiments was 3 which would indicate further optimisation would be required and 
the ECs were exposed to the SS for a period of 24hrs. Although previous studies have shown a 
period of 1-3hrs (Kataoka et al., 1998) is all that is required for conformational change to occur 
within endothelial morphology, it could be that HAECs in this setting require additional time 
of ~48hrs to respond to SS. 
The HAECs under LSS were indicated to have reduced elongation and no changes to cell area 
in this project. This is opposite to what has been reported in literature, where elongation has 
been indicated under LSS (Potter et al., 2012) (Tovar et al., 2019). A potential explanation as 
to why there is a reduced elongation under LSS, could be that LSS may have not been applied 
correctly to the ECs. The HAECS are seeded into a flow chamber and require 24-48hrs 
incubation prior to application of SS. The flow chamber is connected to the fluidic unit 
(Material and Methods Chapter 2) which is a time critical setup due to the possibility of 
introducing an air bubble. It could be that either an inadequate application of SS or the presence 
of an air bubble may have been present during the experiment that lead to the disruption in EC 
layer. This disruption could have easily led to the misalignment of HAECs to the direction of 
flow. Potter and colleagues have reported a similar situation where they used a porcine aorta in 
which they exposed SS. The porcine ECs that did not receive adequate flow inducing SS were 
reported to be of rounded morphology and no alignment towards the direction of flow (Potter 
et al., 2012).  
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3.5.1.1 Clinical relevance  
Under physiological conditions, the endothelium functions to act as a barrier and align to the 
direction of flow maintain a tight confluent network. Under pathological conditions, disruption 
to the endothelium (i.e. endothelial dysfunction) is associated with states of oxidative stress, 
with an increase in oxidative stress. Balaguru and colleagues have reported oscillatory flow 
induced OSS, to be linked with an increase in reactive oxygen species and a decrease in nitic 
oxide (Balaguru et al., 2016). Although nitric oxide and reactive oxygen species have not been 
quantified it can be hypothesized that with the disruption indicated in the alignment to flow, 
HAECs under OSS could have a diminished nitric oxide production which in a clinical setting 
can lead to the exacerbation in disease process i.e. atherosclerosis (Dewey et al., 1981; Davies, 
2009; Chistiakov et al., 2015; Balaguru et al., 2016). Wang and colleagues investigated the 
responses of EC alignment under various flow inducing SS conditions, the outcome of their 
experiment demonstrated that the EC shape (i.e. the cytoskeleton) that determines the 
responses, does not require flow but instead requires a conventional cell shape (Wang et al., 
2013). Thus, strongly suggesting cytoskeletal structures to have an important role in activating 
signalling pathways which can be observed in this study where the HAECs respond to the 
application of OSS. The HAECs appear to orientate the cell shape and alignment in accordance 
to the flow pattern, rather than direction.  
Overall, this project was successful in establishing a human aortic endothelial cell culture and 
applying the respective SS magnitudes along with patterns using the perfusion system. This 
provides an ideal opportunity for the future to study the endothelium in a controlled 
environment with different magnitudes of SS. 
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3.5.1.2 Limitations and further directions.  
There were several limitations such as cell survival, cell confluency, optimising the flow 
conditions to aortic conditions. It was not until several attempts on running SS experiments did 
it become apparent that the overall perfusion system was not able to establish SS magnitudes 
of higher amounts. A brand-new kit was required with dimension suitable to obtain higher 
magnitudes of SS suitable for HAECS.  
The cell culture for HAECs was difficult. When the first primary culture was established post 
arrival, the cells responded well and were subsequently frozen down to maintain several 
samples at lower passage numbers. However, when these frozen passages were subsequently 
thawed and used for experiment it would vary as to which batch of cells would maintain a 
confluent monolayer. The proliferation rate would typically take 2 to 3 days to reach ~80% 
confluency before the cells would require sub-culture. This was not the case for some of the 
samples that were thawed. The proliferation rate went from days to weeks and it was soon 
discovered that there could have been potential mishandling of the frozen aliquots which could 
have led to this delay. In a way to enhance healthy cell viability, an addition of 5% extra FBS 
was used in the cell culture medium to allow for the HAECs to recover. This was successful 
under which the HAECs recovered from delay proliferation. The HAECs were then switched 
back to normal 1% FBS EBM-2 medium.  
Future experiments for HAECs would include exposing the ECs to higher magnitudes of SS. 
This can be achieved by reducing the surface area of the chambers for the perfusion system. A 
longer exposure time should be considered to enable a SS induced response. Another future 
direction would be to stain for the cytoskeletal proteins within the ECs to gain an understanding 
as to what is happening to the exact morphology of the EC when responding to SS.  
A future experiment for HAECs would be the treatments of aldosterone and amiloride. 
HUVECs were used in this project as they were an established cell line within the lab; however, 
to understand the true effects of aldosterone and amiloride on the vascular and cardiac system 
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it is important to study effects of these drugs on the arterial system. Veins and arteries different 
not only in anatomy but also in physiology. The pressures, SS, cyclic stretch and the functional 
purposes differ in a vein and artery. It would also unique to see the effect of these drugs on 
ENaC expression as well.  
It would be interesting to observe the morphological changes HAECs undergo in response to 
the aldosterone and amiloride treatments under LSS and OSS conditions. Especially under the 
OSS conditions as it appears HAECs demonstrate a better response. 
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3.5.2 The effect of SS on HUVEC morphology  
HUVECs were used to study the effect of SS on endothelial morphology but also understand 
the effect on ENaC (Chapter 4). The following section discusses the changes on HUVECs and 
then discusses the effect of aldosterone and amiloride on HUVECs.   
The following was hypothesized for HUVEC morphology under SS conditions: 
1. Increasing the magnitude of SS will cause ECs angle to align to the direction of flow, 
therefore ECs will be elongated and whole cell area will be increased.  
2. Changing the SS pattern from LSS to OSS will not cause ECs angle to align to the 
direction of flow, but ECs will be reduced in elongation and whole cell area will be 
reduced.  
HUVECs exposed to SS were found to align to the direction of flow, elongate and increase in 
cell area with increasing SS. When the SS pattern was changed from LSS to OSS, the elongation 
in HUVECs and cell area was significantly reduced (Figure 13 & 14). Based on these findings, 
the project hypothesis (1 & 2) was confirmed for HUVECs. The only aspect of the hypothesis 
that cannot be confirmed was the angle alignment for HUVECs under OSS, as an alignment to 
the direction of flow was reported (Figure 12).   
These results suggest that with the application of SS, the HUVECs undergo morphological 
changes in response to the magnitude and pattern of SS. Under LSS, the HUVECs were reported 
to align to the direction of flow with elongation occurring of the ECs. This shift in morphology 
suggested that the cytoskeleton was rearranged which facilitated the shift in elongation and also 
the alignment angle (Malek & Izumo, 1996). Previous studies can confirm the changes reported 
in HUVECs as well established, Wechsak and colleagues reported that with an increase in SS 
the cytoskeletal rearrangement is pronounced and faster in comparison to ECs under no SS 
(Wechezak et al., 1985). They also demonstrated LSS to display elongation of ECs and 
alignment towards the direction of flow and reduced elongation with a cobble stone effect on 
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EC morphology under OSS. This supports the findings within this project as the visual images 
of HUVECs under LSS suggested a polygonal appearance in comparison to OSS which had 
more a cobble stone look due to the reduced elongation and cell area.  
In another study, Malek and colleagues were able to establish the changes in morphology to EC 
specific as it was not observed in VSMC and it was also found that the actin fibres within the 
ECs were aligned to the direction of flow, further confirming the HUVEC morphology changes 
under SS (Malek et al., 1996).  
Within a physiological setting, the amount of SS applied in the venous system is varied between 
1 – 6 dyns/cm2, where the vena cava is reported to exhibit a magnitude of ~1 dyns/cm2 SS 
(Davies, 2009). This would suggest that the SS magnitudes of 0 and 10 dyns/cm2 to be 
pathologically relevant as these rates are not seen within the venous system; however the 
HUVECs did maintain a confluent monolayer under the 2 SS magnitudes which would suggest 
the venous ECs to have a greater adaptability to changes in SS magnitude and SS pattern by 
undergoing rearrangement in the cytoskeleton to suit its environment. This would explain the 
benefit of using veins in cardiac bypass graft where the saphenous veins is usually taken to 
replace the coronary vasculature of the heart (Golledge et al., 1997).  
Apart from the endothelial morphology, the expression of ENaC was also investigated in 
relation to SS and its effect within the ECs. To investigate ENaC expression, aldosterone and 
amiloride treatment was administered with and without SS. For the following sections the 
effects of the treatments on EC morphology have been discussed.  
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3.5.2.1 HUVECs treated with aldosterone  
It was hypothesized that treating HUVECs with aldosterone would cause ECs angle to not align 
to the direction of flow, but EC elongation would be reduced and whole cell area will be 
increased.  
HUVECs treated with aldosterone were found to align (angle) to the direction of flow, with 
reduced elongation and increase in cell area. When the SS pattern was changed from LSS to 
OSS, HUVECs did not align to the direction of flow; however, elongated under OSS. Based on 
these results, the study hypothesis was not confirmed as the HUVECs aligned to the direction 
of flow.  
Previous studies have linked aldosterone to increase cell area and reduce elongation (Schneider 
et al., 1997; Gekle et al., 2002; Oberleithner et al., 2003),which has also been observed within 
this project. The alignment of the HUVECs was hypothesized not to align to the direction of 
flow. This might be because HUVECs undergo a rearrangement of the cytoskeleton with the 
exposure of SS; however, aldosterone has been linked to cell stiffness. Therefore, it was 
predicted that alignment of the HUVECs would become impaired due to implications of the 
aldosterone treatment potentially causing the cells to become stiff. Oberleithner and colleagues 
have demonstrated the implications of increased aldosterone on ECs caused an increase in 
plasma sodium concentration resulting in stiff cells (Oberleithner et al., 2006a). This however 
was not confirmed as it was not quantified in HUVECs and could be explained by the fact the 
sodium concentration within the endothelial medium was unchanged and only the aldosterone 
was added on.  
The changes seen within the cell area within in study can be explained by the increase in fluid 
transport. This is believed to be via a mineral-corticoid receptor dependent mechanism i.e. 
increase in ENaC expression (analysed in Chapter 4). An increase in cell volume due to 
aldosterone treatment is not ideal for the ECs as this has been reported to induce oxidative stress 
within the endothelium (Fels et al., 2010). Animal studies by Kasal and colleagues have 
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demonstrated a reduction in NO production linked to endothelial dysfunction with an increase 
in aldosterone infusion administered to the mice and rats (Kasal et al., 2012). Oberleithner and 
colleagues used atomic force microscope to demonstrate cell stiffening which is implicated in 
reduced NO production (Oberleithner et al.,2003). Collectively, these studies combined suggest 
that the treatment of aldosterone is detrimental on the endothelium. With this project, there was 
also the addition of SS with aldosterone that was found to increase the elongation under 
increasing OSS, and cell area was increased under OSS. This would suggest that aldosterone 
induced treatment is exacerbated under oscillatory pattern which in clinical terms would mimic 
a state of hypertension or even advanced cardiovascular disease where the flow pattern has 
become oscillatory (Davies, 2009). Oberleithner and colleagues demonstrated HUVECs 
swelling with the application of 1nM over a 3-day period. To their surprise it was linked to an 
accumulation of organic matter, with a reduction in the cellular fluid. This induced stiffness 
within the endothelium making it vulnerable to SS. Based on the study’s results it was suggested 
that under clinical settings of hypertension combined with increased aldosterone within the 
plasma could lead to endothelial dysfunction. From this study it could be implicated that the 
time period in this project for aldosterone maybe have been short. Although mechanistically 
aldosterone has two time phases of actions, a short phase (i.e within a couple of hours) and a 
long phase which can take up to 24hrs (Schafer et al., 2002). With the application of an active 
flow via the perfusion system a longer period of ~48 to 72 hrs may have been required to see a 
greater or enhanced effect on endothelial morphology.  
  
3. Endothelial Morphology 
94 
3.5.2.2 HUVECs treated with amiloride  
For HUVECs treated with amiloride, it was hypothesized that with the exposure of SS it will 
cause ECs to align to the direction of flow, ECs will be elongated; whole cell area will be 
reduced.  
In this study HUVECs treated with amiloride aligned to the direction of flow, elongated with 
no SS and cell area was increased. Changing the SS pattern from LSS to OSS caused the 
HUVECs to not align to the direction of flow, and there was no elongation (Figure 24) and the 
cell area (Figure 25) was decreased under 5 dyns/cm2 and increased under 10 dyns/cm2. Based 
on these findings, the hypothesis was not confirmed as the HUVECs did not elongate under SS 
and cell area was changed variably with increasing SS magnitude.  
Amiloride is a drug used to inhibit the channel current of ENaC (Kleyman et al., 1998). For this 
project is has been used to investigate the effect on ENaC expression and the overall effect it 
would elicit on endothelial morphology (Alliegro et al., 1993; Kusche-Vihrog et al., 2008a). 
The effect of amiloride on ENaC expression will be discussed in Chapter 4; however the effect 
on the EC morphology could be potentially be linked to ENaC expression/ activity due to the 
electrolyte balance the channel regulates (Oberleithner et al., 2006b). There are limited studies 
that have acknowledged the effect of amiloride on EC morphology (Alliegro et al., 1993; 
Oberleithner et al., 2006a). An early study by Alliegro and colleagues investigated the effects 
of amiloride on ECs and were able to report an inhibition on EC proliferation, it was suggested 
that amiloride could trigger the release of anti-proliferative factors (Alliegro et al., 1993). 
Although the proliferation was not quantified in this project, the images taken of HUEVCs 
treated with amiloride do not suggest a reduction in proliferation.  
With regards to the HUVECs elongation, this was observed under no SS following the 
application of amiloride. This suggested that the HUVECs compensate for the blockade of 
channels, and transporter that regulate the electrolyte balance to maintain a homeostatic 
environment via undergoing potential cytoskeletal rearrangement. The cell area for HUVECs 
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treated with amiloride demonstrated an interesting response. With the application of LSS, there 
was an increase with 5 dyns/cm2 and then a decrease under 10 dyns/cm2, this change was 
opposite to the HUVECs exposed to SS only where the area increased with increasing SS. A 
potential hypothesis to explain this change in area would be that despite amiloride blocking 
selective ion channels, the application of SS would, therefore, activate other non-amiloride 
sensitive ion channels or transporter which could potentially facilitate a compensation in 
electrolyte balance. Oberleithner and colleagues demonstrated that amiloride treatment on 
HUVECs did not affect the cell stiffness, as there was a reduction in cell stiffness induced by 
aldosterone (Oberleithner et al., 2007). However Prystopiuk and colleagues reported a 
reduction in cell stiffness with the application of amiloride as there was reported increase in 
response to the application of hydrostatic pressure (Prystopiuk et al., 2018). These studies 
suggest that amiloride is involved in selectively blocking ion channels which would enable for 
an imbalance in electrolytes leading to an increase in oxidative stress and a reduction in the NO 
production.  
The results reported from these amiloride experiments on HUVEC morphology are still 
preliminary. To postulate an exact mechanism to explain the morphological changes would be 
difficult without conducting further experiments to analyse the changes on the cytoskeleton of 
the ECs. The application of SS on HUVECs also makes it difficult to conclude whether the 
changes observed are amiloride induced, SS induced or a combined effect on HUVEC.   
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3.5.2.3 Clinical relevance   
In a clinical setting, aldosterone excess is reported in patients with developed cardiovascular 
disease and hypertension. At the endothelial level, an increase in aldosterone is linked with 
increased cell stiffness (Wildling et al., 2009). Amiloride on the other hand is prescribed as an 
anti-diuretic to help with stabilisation in fluid management for patients with cardiovascular 
disease. Studies have found that amiloride to improves endothelial function which can be linked 
to the blockade of aldosterone and selective ion channel activity (Martinez-Lemus et al., 2017).  
With regards to morphology, the changes due to aldosterone could suggest that ECs would 
become dysfunctional and exacerbate oxidative stresses within the endothelium (Prystopiuk et 
al., 2018). With the application of amiloride, it has already been reported that the endothelial 
function is improved, especially with a decrease in cell stiffness noted (Oberleithner et al., 
2006a; Prystopiuk et al., 2018).  
This project is the first to examine the effect of aldosterone and amiloride on HUVECs with the 
application of SS induced by flow. This enables the possibilities to study the changes to the 
morphology to a greater extensive whilst replicating the in vivo environment as closely within 
an experimental set up.  
3.5.2.4 Limitations and Future directions  
There were several limitations of this project for the HUVEC experiments. One of the 
limitations was that this project utilised HUVECs which are a venous system ECs but also from 
an umbilical origin where the umbilical vein is characterised to arterial SS magnitudes in 
comparison to an adult vein. The purpose of using HUVECs was because it is a well-established 
cell model within the field of studying EC morphology and has been utilised in several studies 
mentioned above when investigating the effects of SS, aldosterone and amiloride. The 
limitation this creates is the relevance that can be made to a clinical environment. To establish 
a protocol and utilise the ECs to understand how they respond to treatments and mechanical 
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stimuli is good. But an appropriate venous and arterial cell line is required to implement a 
clinical relevance. This was done with the establishment of HAECs in the early experiments.  
The removal of FBS from the medium was detrimental and lead to HUVECs becoming 
unstable, not confluent and not establishing a monolayer within the ibid chambers. This was 
removed to control for the exact amount being added into the medium. This was done for the 
amiloride treatment as well. Therefore, FBS was added back into the medium. The likelihood 
of it affecting the aldosterone concentration of 10nM is low; however, it is being acknowledged 
a potential limitation which could have effected HUVECs and no change was reported within 
the cell area.  
Another limitation for these experiments was time. The time of exposing and treating the 
HUVECs with SS and the specific treatments was 24hrs. As mentioned already, previous 
studies have reported changes in EC morphology within a shorter time period. This could be 
different for ECs being exposed to a combined treatment of aldosterone or amiloride with SS.  
For future studies, further experiments are required to gain a better understanding to the EC 
changes reported under SS and treatment. These include: 
1. Longer time exposures for SS and aldosterone/amiloride treatments  
2. Investigating the cytoskeleton, actin, tubulin and other proteins under SS conditions.  
3. Replicating the aldosterone and amiloride experiments using arterial ECs i.e. HAECs.  
 
  










4. Characterising the gene expression of ENaC subunits in 
endothelial cells, with the exposure of SS on HAECs and 
the application of aldosterone and amiloride on HUVECs. 
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Despite the recognised effect of SS on endothelial morphology (Chapter 3) and the 
rearrangement of the cytoskeleton, little is known about the mechanism and sensors involved. 
In this project, the changes in endothelial morphology have been reported and a possible ion 
channel involved in regulating the SS is hypothesized as the epithelial sodium channel (ENaC). 
Although the exact mechanism cannot be fully investigated in this project, the gene expression 
of ENaC was investigated under SS and with the additional treatment of aldosterone and 
amiloride.  
ENaC has be extensively studied within the vascular smooth muscle cells, the channel has been 
shown to indirectly modulate vascular tone (Jernigan & Drummond et al., 2005), and vascular 
resistance. The effect of ENaC on the endothelium is limited but it was hypothesized that ENaC 
is  involved in the endothelium responsiveness to SS which is essential for vascular function. 
Due to the differences in SS between the arterial and venous system, this project used an aortic 
cell line and a vein cell line to quantify ENaC. It is important to note that the main objective for 
HAECs was to detect the expression of ENaC and to further quantify the changes in ENaC 
under LSS and OSS. To investigate the effect of ENaC under SS and particularly within the 
ECs, HUVECs were selected as the standard model for further experiments including the 
application of aldosterone and amiloride.  
The following chapter will discuss ENaC expression in HAECs and HUVECs under increasing 
SS conditions, changing SS patterns (e.g. LSS to OSS) and under aldosterone and amiloride 
treatment. Note, only HUVECs were treated with aldosterone and amiloride with SS as HAECs 
still required optimisation under SS conditions.  
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4.1. HAECS 
To date, no study has reported the gene expression of the epithelial sodium channel (ENaC) 
within human aortic endothelial cells (HAECs). Therefore, part of the second objective was to 
detect the gene expression of ENaC at messenger RNA (mRNA) level within HAECs and to 
further investigate the changes in gene expression after exposure to LSS and OSS. The 
subsections focused on the effect of increasing SS and then changing the pattern from LSS to 
OSS. It is important to note that the gene expression of ENaC subunits does not represent the 
protein expression. Gene expression can be altered before protein expression is altered.  
4.1.1 The effect of increasing SS on ENaC subunits gene expression 
HAECs were exposed to SS rates of 0, 10 and 15 dyns/cm2 LSS and OSS for a period of 24 
hours. Cell lysates were collected after each experiment and then analysed using quantitative 
polymerase chain reactions (q-PCR) to quantify the gene expression for ENaC.  
4.1.1.1 Increasing LSS does not change ENaC gene expression in HAECs.  
The qPCR was able to detect ENaC gene expression for all four subunits in HAECs. The gene 
expression for ENaC under 0, 10 and 15 dyns/cm2 LSS did not change. Overall, results indicated 
a low ENaC gene expression with the transcripts being detected at cycle 30 to 32 (Figure 26 
n=3). This was consistent with the detection of ENaC gene expression done in human aortic 
punches, currently being conducted in the Fronius lab.  
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Figure 26. ENaC gene expression in HAECs under LSS (0, 10 & 15 dyns/cm2). (A) αENaC, (B) βENaC, (C) γENaC, 
(D) δENaC. ENaC expression for all 4 subunits within HAECs remains unchanged under LSS post 0, 10 and 15 dyns/cm2 
Data presented as Mean ± SEM n=3 one-way ANOVA, Sidak's multiple comparisons test, Mann Whitney test  
 
In summary the gene expression for ENaC subunits was detected in HAECs. These results are 
preliminary and require further replications to establish the expression. It was interesting to note 
that the detection of the ENaC gene expression was quite low within the HAECs and the 
application of LSS suggested a higher expression with increasing SS magnitude, although not 
statistically significant.   
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4.1.1.2 Higher magnitudes of OSS increased β-ENaC gene expression in HAECs 
HAECs exposed to OSS induced a significant increase in β-ENaC gene expression under 15 
dyns/cm2 (0.005135 ± 0.001, n=3) in comparison to 0 (0.001056 ± 0.0007, p< 0.05, n=3) and 
10 dyns/cm2 (Figure 27B, 0.0007421 ± 0.0006, p< 0.05, n=3). This increase in β-ENaC gene 
expression does not mean an increase in protein expression (i.e. surface ENaC protein 
expression). The remaining ENaC subunits did not change with increasing SS under OSS 
(Figure 27A, C & D, p<0.05).  
 
Figure 27. ENaC gene expression in HAECs under OSS (0, 10 & 15 dyns/cm2). (A) αENaC, (B) βENaC, (C) γENaC, 
(D) δENaC. ENaC expression for α, γ and δ subunits within HAECs remains unchanged under OSS post 0, 10 and 15 dyns/cm2 
(A, C &D). β-ENaC increased under 15 dyns/cm2 in comparison to 0 and 10 dyns/cm2 (p< 0.05) (B). Data presented as Mean 
± SEM n=3 *p<0.05, one-way ANOVA, Sidak's multiple comparisons test, Mann Whitney test  
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4.1.2 Changing SS from LSS to OSS increases β-ENaC gene expression in HAECs  
Following the exposure of increasing SS, the pattern of SS was analysed to determine whether 
there was a difference in ENaC gene expression under the exposure of LSS vs OSS. When the 
SS experiments were compared for LSS and OSS, an increase in gene expression was noted for 
β-ENaC gene expression (Figure 28B, 0.0004583 ± 0.0003 to 0.005135 ± 0.0010, p< 0.05, n=3) 
under 15 dyns/cm2 OSS in comparison to LSS. The remaining ENaC subunits remained 
unchanged with the change in SS pattern from LSS to OSS (Figure 28A, C & D, p >0.05, n=3).  
 
 
Figure 28. ENaC gene expression in HAECs, LSS vs OSS (α, β, γ, δ ENaC) (A) 0, (B) 10 (C) 15 dyns/cm2. ENaC 
expression for the β subunit is increased under OSS post 15 dyns/cm2 in comparison to LSS (p=0.05) (C). All other subunits 
did not show a significant change when compared under LSS and OSS post 0 and 10 dyns/cm2 (A & B). The data has been 
presented as a Log graph due to the relative gene expression being exceptionally low. The log graph was used for presentation. 
Data presented as Mean ± SEM n=3 *p<0.05, multiple t-tests. Note this does not represent changes in protein expressions.  
 
In summary, ENaC gene expression was successfully detected in HAECs and an increase in β-
ENaC gene expression was noted under OSS conditions, which supplements the morphology 
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data of how the cells responded well to the OSS conditions with higher SS magnitudes. If there 
is a direct correlation between the morphology changes being influenced by ENaC, protein 
expression would need to be quantified which was not fully established for this project.   
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4.1.3 α-ENaC and δ-ENaC gene were similarly expressed in HAECs 
The fourth ENaC subunit, δ-ENaC has not been fully understood since its discovery. This 
project investigated the differences in α-ENaC and δ-ENaC gene under SS and found no 
changes in gene expression in HAECs (Figure 29, p >0.05, n=3). It has been reported that δ-
ENaC forms an atypical ion channel with β,γ-ENaC, similar to that of α-ENaC (Wichmann et 
al., 2018). A recent study by Wichmann has been able demonstrate δ-ENaC to have a different 
expression pattern compared with α-ENaC (Wichmann et al., 2018). Although this difference 
was reported in Xenopus Laevis, little is known of the differences in α/δ-ENaC expression 
pattern.  
 
Figure 29. α-ENaC vs δ-ENaC gene expression in HAECs. ENaC gene expression for the β subunit is increased under 
OSS post 15 dyns/cm2 in comparison to LSS (p=0.05) (C). All other subunits did not show a significant change when 
compared under LSS and OSS post 0 and 10 dyns/cm2 (A & B). The data has been presented as a Log graph due to the 
relative gene expression being very low. The log graph was used for presentation. Data presented as Mean ± SEM n=3 
*p<0.05, multiple t-tests. Filled and unfilled key indicate the pattern of SS, black = LSS and unfilled=OSS 
 
This project was the first to detect ENaC gene expression in HAECs and exposure of SS 
suggests an increase in gene expression. Though, this does not provide an increase in protein 
expression. To understand ENaC expression in ECs, HUVECs were utilised to further 
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investigate the expression with aldosterone and amiloride as further optimization was required 
for HAEC cell culture.  
In summary for HAECs, this study has been able to successfully detect the gene expression for 
all four ENaC subunits. Although an increase in β-ENaC gene expression was noted with OSS, 
as mentioned above, this does not indicate an increase protein level. It was also noted that the 
gene expression was exceptionally low and that suggested that potentially ENaC does not hold 
a significant role in altering endothelial properties. This assumption is based on anatomical 
structure of an artery, where there are also the smooth muscle cells that have been detected to 
have expression of ENaC subunits, both protein and gene. Whether ENaC truly plays an 
important role regulating endothelial function and can exacerbate endothelial dysfunction, 
further experiments are required including additions of aldosterone and amiloride. The 
following sections investigate the effects of aldosterone and amiloride on HUVECs which are 
already established to have ENaC gene expressions.   
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4.2 HUVECs  
Following the detection of ENaC in HAECs, ENaC expression in HUVECs was analysed. 
Previous studies have identified the protein and gene expression of α, β, γ, and δ-ENaC subunits 
within HUVECs and a previous project in the Fronius lab has confirmed the expression of 
ENaC in HUVECs (unpublished data Fronius Lab 2017). For this project, the gene expression 
was analysed and then further treatments of aldosterone and amiloride were used to investigate 
the effects on ENaC.  
4.2.1 LSS increases γ-ENaC gene expression in HUVECs under 5 dyns/cm2, decreases 
under 10 dyns/cm2 
HUVECs exposed to LSS induced an increase in γ-ENaC gene expression under 5 dyns/cm2 
(Figure 30C, 0.000712 ± 0.0001, n=4) in comparison to 0 dyns/cm2 (Figure 28C, 0.0001875 ± 
0.000016, p< 0.05, n=4). This increase in gene expression under 5 dyns/cm2 was abolished 
when HUVECs were exposed to 10 dyns/cm2 (0.0002027 ± 0.0001, p< 0.05, n=4).  
A decreasing trend was observed for β-ENaC, under 10dyns/cm2 from 5 dyns/cm2 (Figure 28B, 
0.007541 ± 0.002 to 0.0004435 ± 0.0001, p=0.07, n=4). A similar decreasing trend in gene 
expression was also observed for δ-ENaC from 5 dyns/cm2 to 10 dyns/cm2 (Figure 30D, 
0.00221 ± 0.0006, 0.0002544 ± 0.0001, p=0.06, n=4). For α-ENaC, no change was indicated 
under LSS (Figure 30A, p>0.05, n=4) 
  




Figure 30. ENaC gene expression in HUVECs under LSS (0, 5 & 10 dyns/cm2). (A) αENaC, (B) βENaC, (C) γENaC, 
(D) δENaC mRNA. ENaC gene expression in HUVECs under LSS was low in overall. Expression for γENaC increased 
under 5 dyns/cm2 and decreased under 10 dyns/cm2 (C) (p=0.05). A decreasing trend was observed for βENaC and δENaC 
post 10 dyns/cm2 in comparison to 5 dyns/cm2; however, this change was not statistically significant (B & D) (p=0.06) 
subunits αENaC did not change. Data presented as Mean ± SEM *p<0.05, n=4 one-way ANOVA, Sidak's multiple 
comparisons test, Mann Whitney test. 
 
In summary, ENaC gene expression was confirmed in HUVECs and an increase in γ-ENaC was 
noted under 5 dyns/cm2 LSS. Although not quantified, the gene expression for ENaC subunits 
was seen to be higher in HUVECs in comparison to the HAECs.  
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4.2.2 Increasing OSS did not change ENaC gene expression in HUVECs  
The expression for α, β, γ and δ-ENaC under 5 and 10 dyns/cm2 OSS did not change. A 
decreasing trend was observed in γ-ENaC under 10 dyns/cm2 (Figure 31C, 0.0003349 ± 0.0001, 
n=4) in comparison to 5 dyns/cm2 (Figure 31C, 0.000419 ± 0.0001, p= 0.07, n=4). 
 
Figure 31. ENaC gene expression in HUVECs under OSS (0, 5 & 10 dyns/cm2). (A) αENaC, (B) βENaC, (C) γENaC, 
(D) δENaC. ENaC gene expression in HUVECs under OSS was overall low and any changes exhibited in are not statistically 
significant. Data presented as Mean ± SEM *p<0.05, n=4 one-way ANOVA, Sidak's multiple comparisons test, Mann 
Whitney test. 
 
Overall, HUVECs exposed to OSS conditions depicted no changes in ENaC gene expression. 
It does appear that some of the ENaC subunits have high expression but are not statistically 
significant. This could be due various factors, including contamination of the cell samples 
which can contribute to inaccurate readings. Further experiments would be required to establish 
a true effect of OSS on ENaC gene expression.  
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4.2.3 Changing the pattern of SS from LSS to OSS decreases β-ENaC gene expression.  
To determine which SS pattern influenced ENaC gene expression, both LSS and OSS 
conditions were compared. A decrease in β-ENaC was induced under 5 dyns/cm2 OSS in 
comparison to 5 dyns/cm2 LSS (Figure 32B, 0.008 ± 0.003 to 0.0000334 ± 0.00002, p<0.05, 
n=4). For the remaining ENaC subunits, α, γ & δ-ENaC, did not change in gene expression 
when the SS pattern was changed. This suggested that OSS has a reducing effect on ENaC gene 
expression in comparison to LSS which suggested an increasing effect.  
 
 
Figure 32. ENaC gene expression in HUVECs LSS vs OSS (0, 5 & 10 dyns/cm2). (A) αENaC, (B) βENaC, (C) 
γENaC, (D) δENaC. ENaC gene expression for the β subunit is decreased under OSS post 10 dyns/cm2 in comparison to 
LSS (p=0.05) All other subunits did not show a significant change when compared under LSS and OSS post. Data 
presented as Mean ± SEM *p<0.05, n=4 one-way ANOVA, Sidak's multiple comparisons test.  
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4.2.4 Gene expression levels of α-ENaC and δ-ENaC did not change under SS in HUVECs 
The gene expression levels of α-ENaC and δ-ENaC did not statistically change under LSS; 
however increasing trend was observed for δ-ENaC under 5 dyns/cm2 LSS in comparison to α-
ENaC (Figure 33A, α-ENaC 0.0001 ± 0.00002 vs δ-ENaC 0.002 ± 0.0007, p=0.06, n=4) and 0 
dyns/cm2 (Figure 33A, α-ENaC 0.0002 ± 0.00007 vs δ-ENaC 0.001 ± 0.0005, p=0.07, n=4).  
Under OSS, α-ENaC and δ-ENaC did not change in expression levels; however increasing trend 
was observed for δ-ENaC under 0 dyns/cm2 LSS in comparison to α-ENaC (Figure 33B, α-
ENaC 0.0002 ± 0.00002 vs δ-ENaC 0.001 ± 0.0007, p=0.07, n=4) and 5 dyns/cm2 (Figure 33B, 
α-ENaC 0.0001 ± 0.00007 vs δ-ENaC 0.001 ± 0.0005, p=0.1, n=4). 
 
Figure 33. α-ENaC and δ-ENaC gene expression in HUVECs under (A) LSS and (B) OSS (0, 5 & 10 dyns/cm2). α-
ENaC and δ-ENaC gene expression in HUVECs did not change under LSS or OSS. Data presented as Mean ± SEM, n=4 
one-way ANOVA, Sidak's multiple comparisons test Mann Whitney test. Filled and unfilled  key indicate the pattern of SS, 
black = LSS and unfilled=OSS.  
 
In summary, this section investigated the gene expression of ENaC. It was found that with 
exposing HUVECs to SS there was a change in gene expression which is a first to be reported 
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within the Fronius lab. ENaC gene expression is suggested to increase under LSS and decrease 
with OSS. Although further studies would be required to establish the true changes in gene 
expression, and it is important to note that the gene expression changes do not depict the 
changes in protein expression. The protein expression for ENaC can take a period of further 24 
hrs to increase but can also be immediate depending on the subvesicle storage of channels that 
can occur below the surface membrane. This would be an excellent opportunity to investigate 
the changes in protein expression in future to see if there is an immediate change in ENaC 
protein expression and this would provide a stronger evidence-based concept of ENaC 
influencing endothelial morphology and other endothelial properties.  
In this study, there are several graphs that have compared the gene expression of delta ENaC 
with alpha ENaC. This has been done due to the potential idea that the delta ENaC is the 
predominant ENaC subunit to form the channel along with beta and gamma, in comparison to 
the alpha subunit. In figure 33, although not statistically significant, a trend of higher delta 
ENaC expression in comparison to alpha ENaC is demonstrated in HUVECs. Whether in fact 
delta ENaC is indeed the predominant subunit to form the ion channel, further testing would be 
required.  
In the next section, HUVECs treated with aldosterone and amiloride were analysed for ENaC 
gene expression. It was predicted that the treatment of aldosterone would lead to a increase in 
ENaC gene expression but the effect of amiloride would be minimal due to it being a channel 
activity blocker.   
 4. ENaC expression 
113 
4.3 Aldosterone treated HUVECs with increasing SS.  
By this stage of the project, ENaC gene expression had been confirmed in HUVECs and the 
gene expression was analysed under different SS conditions. To further investigate ENaC’s role 
in sensing SS, aldosterone and amiloride were selected to treat HUVECs with and without SS 
to establish what ENaC’s role is within the endothelium. Aldosterone was selected as it is a 
steroidal hormone which acts on ENaC expression regulation and amiloride was selected for 
blocking ENaC and the inwards sodium influx. Overall, the application of these treatments with 
the exposure of SS was done to investigate the effect on ENaC gene expression.  
Ideally, HAECs should have been used but further optimisation is required to establish them 
into a stable cell culture. The following sections focus on aldosterone and amiloride application 
of HUVECs under no SS (0), 5 and 10 dyns/cm2 LSS and OSS and the effect on ENaC 
expression at mRNA level.  
4.3.1 α-ENaC and δ-ENaC gene expression increased in aldosterone treated HUVECs 
with higher LSS  
HUVECs exposed to LSS with aldosterone treated did demonstrate changes in ENaC 
expression, particularly with α-ENaC were an increase was induced under 5 dyns/cm2 (Figure 
34A, 0.0001867 ± 0.00001, p< 0.05, n=4) in comparison to 0 dyns/cm2 (Figure 34A, 0.0000807 
± 0.00001, p< 0.05, n=4).. A further increase was induced for α-ENaC under 10 dyns/cm2 
(Figure 32A, 0.0004611 ± 0.0001, p< 0.05, n=4) in comparison to 5 dyns/cm2 (Figure 34A, 
0.0001867 ± 0.00001, p< 0.05, n=4) and this was also significant to 0 dyns/cm2 (Figure 34A, 
0.0000807 ± 0.00001, p< 0.05, n=4). 
An increase in expression was also induced for δ-ENaC under 10dyns/cm2 (Figure 34D, 
0.0006246 ± 0.00021, p< 0.05, n=4) in comparison to 0 dyns/cm2 (Figure 34A, 0.0003888 ± 
0.00007, p< 0.05, n=4). For the remaining subunits of β-ENaC and γ-ENaC gene expression 
did not change with aldosterone treatment under LSS (Figure 34B & C, p<0.05, n=4).  
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Figure 34. ENaC gene expression in aldosterone treated HUVECs under LSS (0, 5 & 10 dyns/cm2). (A) αENaC, (B) 
βENaC, (C) γENaC, (D) δENaC. α-ENaC gene expression increased with increasing LSS (p<0.05). δ-ENaC, increased 
under 10 dyns/cm2 in comparison to no SS with aldosterone treatment. β and γ-ENaC did not change with increasing SS 
under aldosterone treatment. Data presented as Mean ± SEM *p<0.05, **p<0.001, ****p<0.00001 n=4 one-way ANOVA, 
Sidak's multiple comparisons test.  
 
In summary, HUVECs treated with aldosterone 10 nM and exposed to LSS were found to 
have increased ENaC gene expression. More specifically, the gene expression was increased 
for α-ENaC and δ-ENaC. The remaining subunits did not have a statistically significant 
change in gene expression. This is a positive indication of showing that the drug treatment 
does have and effect on gene expression. As the experiments done without the SS conditions 
revealed beta ENaC gene expression to increase under LSS conditions.  
The following section analysed the gene expression for HUVECs under OSS conditions and 
with aldosterone.   
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4.3.2 α-ENaC and δ-ENaC gene expression increased in aldosterone treated HUVECs 
with increasing OSS. 
HUVECs treated with aldosterone and under OSS did increase in ENaC gene expression, 
particularly with α-ENaC where an increase was induced under 5 dyns/cm2 (Figure 35A, 
0.00257 ± 0.0002, p< 0.05, n=4) in comparison to 0 dyns/cm2 (Figure 35A, 0.0000807 ± 0.0003, 
p< 0.05, n=4). Following the increase in OSS to 10 dyns/cm2, α-ENaC gene expression was 
decreased (Figure 33A, 0.0006295 ± 0.0003, p< 0.05, n=4) in comparison to 5 dyns/cm2 (Figure 
35A, 0.00257 ± 0.0002, p< 0.05, n=4). This was not expected as it was hypothesized that with 
aldosterone the gene expression of all ENaC subunits would increase, not decrease.  
An increase in ENaC gene expression was also induced for δ-ENaC under 10 dyns/cm2 (Figure 
33D, 0. 0007943 ± 0.0007, p< 0.05, n=4) in comparison to 0 dyns/cm2 (Figure 35D, 0.000388 
± 0.0002, p< 0.05, n=4). The remaining ENaC subunits of β-ENaC and γ-ENaC did not change 
with aldosterone treatment and increasing OSS (Figure 35B, C, p>0.05, n=4) 
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Figure 35. ENaC gene expression in aldosterone treated HUVECs under OSS (0, 5 & 10 dyns/cm2). (A) αENaC, (B) 
βENaC, (C) γENaC, (D) δENaC. α-ENaC increased in gene expression under 5 dyns/cm2 (p<0.05) and was reduced under 
10 dyns/cm2 (p<0.05). δ-ENaC increased in gene expression under 10 dyns/cm2 in comparison to no OSS. The remaining 
subunits did not change under OSS with aldosterone treatment. Data presented as Mean ± SEM *p<0.05, **p<0.001 n=4 
one-way ANOVA, Sidak's multiple comparisons test Mann Whitney test.  
 
These changes see for HUVECs treated with aldosterone in ENaC gene expression under OSS 
are like that of the ENaC gene expression under LSS and aldosterone. It would be interesting 
to see if there is any differences in the increases noted for the gene expressions for ENaC. It 
would be also interesting to see in future what happens to the protein expression as well.  
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4.3.3 ENaC gene expression increases under OSS in aldosterone treated HUVECs.  
HUVECs treated with aldosterone and exposed to OSS demonstrated an increase in ENaC gene 
expression compared to LSS. An increase in gene expression was induced for α-ENaC (Figure 
36A, 0.0001867 ± 0.0003 to 0.00257 ± 0.0001, p<0.01, n=4), β-ENaC (Figure 36B, 0.008 ± 
0.003 to 0.0000334 ± 0.00002, p<0.05, n=4) and γ-ENaC under 5 dyns/cm2 OSS compared to 
LSS (Figure 36). 
 
Figure 36. ENaC gene expression in aldosterone treated HUVECs LSS vs OSS (0, 5 & 10 dyns/cm2). (A) αENaC, (B) 
βENaC, (C) γENaC, (D) δENaC. Changing the SS pattern from LSS to OSS caused an increase α, β, δ-ENaC expression 
under 5 dyns/cm2 OSS. Under 10 dyns/cm2 OSS, β, γ, δ-ENaC increased in expression. Data presented as Mean ± SEM 
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4.3.4 δ-ENaC gene expression is increased under LSS and α-ENaC is increased under OSS 
with aldosterone.  
In this study, there are several graphs that have compared the gene expression of delta ENaC 
with alpha ENaC. This has been done due to the potential idea that the delta ENaC is the 
predominant ENaC subunit to form the channel along with beta and gamma, in comparison to 
the alpha subunit. The following experiment will demonstrate the effect aldosterone has on the 
gene expression for ENaC subunits.  
HUVECs treated with aldosterone and no SS induced an increase in δ-ENaC gene expression 
in comparison to α-ENaC (Figure 37, 0.0004 ± 0.0003 vs 0.00008 ± 0.000001, p<0.01, n=4). 
An increase was also induced for δ-ENaC under 10 dyns/cm2 LSS in comparison to α-ENaC 
(Figure 37A, 0.0006 ± 0.0003 vs 0.0004 ± 0.00001, p<0.01, n=4).  
HUVECs treated with aldosterone and OSS, induced an increase in α-ENaC in comparison to 
δ-ENaC under 5 dyns/cm2 (Figure 37B, 0.00063 ± 0.0003 vs 0.00008 ± 0.00003, p<0.01, n=4). 
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Figure 37. α-ENaC vs δ-ENaC gene expression in aldosterone treated HUVECs under LSS (A) & OSS (B) (0, 5 & 10 
dyns/cm2). A reported increase was demonstrated under δ-ENaC in comparison to α-ENaC under LSS. Under OSS, an 
increase in α-ENaC was seen in comparison to δ-ENaC (p<0.05). Data presented as Mean ± SEM *p<0.05, n=4 one-way 
ANOVA, Sidak's multiple comparisons test Mann Whitney test. Filled and unfilled key indicate the pattern of SS, black = 
LSS and unfilled=OSS 
 
In summary, HUVECs treated with aldosterone demonstrate an increase in ENaC gene 
expression with exposure to OSS conditions in comparison to LSS. This would suggest in an 
pathological environment of OSS, an influx of aldosterone whether it be diet or dysfunction can 
increase ENaC gene expression. This can be reported for all four ENaC subunits. However, it 
was interesting to note that the effect of aldosterone on ENaC gene expression was considerably 
higher for α-ENaC and δ-ENaC gene expression (Figure 37). Thus, suggesting that the ENaC 
channels being synthesized are predominantly of either α-ENaC and/or δ-ENaC combination. 
It is important to note this is purely hypothetical due to the fact there is no protein quantification 
done as part of this study and that the changes noted in the gene expression do not replicate into 
the changes noted in the protein expression. The following section investigated the effects of 
amiloride with was hypothesized to decrease ENaC gene expression.   
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4.4 Amiloride treated HUVECs with increasing SS 
HUVECs treated with amiloride were exposed to increasing SS. Under increasing LSS, an 
increase in α-ENaC gene expression was indicated under 10 dyns/cm2 in comparison to no SS 
and 5 dyns/cm2 (Figure 38A, 10 dyns/cm2, 0.0003 ± 0.000001 vs 0 dyns/cm2, 0.00008 ± 0.00002 
& 5 dyns/cm2, 0.00003 ± 0.00004, p<0.01, n=4). The remaining subunits did not change in 
gene expression under increasing LSS with amiloride treatment.  
 
 
Figure 38. ENaC gene expression in amiloride treated HUVECs under LSS (0, 5 & 10 dyns/cm2). (A) αENaC, (B) 
βENaC, (C) γENaC, (D) δENaC. α-ENaC is increased in gene expression with increasing LSS under amiloride treatment. 
All other subunits remain unchanged. Data presented as Mean ± SEM *p<0.05, **p<0.001 n=4 one-way ANOVA, Sidak's 
multiple comparisons test Mann Whitney test 
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HUVECs treated with amiloride and exposed to increasing OSS demonstrated an increase in γ-
ENaC gene expression under 5 dyns/cm2 in comparison to no SS (Figure 39C, 0.001738 ± 
0.0001 vs 0.0001 ± 0.0001, p<0.01, n=4); however a decrease in gene expression was noted for 
γ-ENaC when the OSS was increased to 10 dyns/cm2 (Figure 39C, 0.0002 ± 0.0007 vs 0.001738 
± 0.0001, p<0.01, n=4). 
An increase in δ-ENaC gene expression was indicated under 10 dyns/cm2 in comparison 5 
dyns/cm2 (Figure 39D, 0.00092 ± 0.0001 vs 0.0003 ± 0.0001, p<0.05, n=4).  
 
Figure 39. ENaC gene expression in amiloride treated HUVECs under OSS (0, 5 & 10 dyns/cm2). (A) αENaC, (B) 
βENaC, (C) γENaC, (D) δENaC. γ-ENaC was increased under 5dyns/cm2 and then reduced under 10 dyns/cm2 (p<0.05). 
An increase in δ-ENaC was noted under 10dyns/cm2 in comparison to 5 dyns/cm2 (p<0.05). Data presented as Mean ± SEM 
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In summary, α-ENaC gene expression was increased in HUVECs treated with amiloride under 
LSS. This was quite the opposite of what was predicted (Figure 38). 
For the OSS data (Figure 39), γ-ENaC and δ-ENaC altered in gene expression in HUVECs 
treated with amiloride, exposed to OSS. These results would suggest that the amiloride has 
more of an effect on ENaC gene expression under OSS, in comparison to the results 
demonstrated in Figure 38 for LSS conditions. The following section investigates the effects of 
amiloride on HUVECs but also compares the different SS conditions to see any changes in 
ENaC gene expression.   
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4.4.1 Changing LSS to OSS increases α & γ-ENaC but decreases β & δ-ENaC 
Changing the SS pattern from LSS to OSS under amiloride treatment increased α-ENaC gene 
expression (Figure 40A, 0.00005 ± 0.0007 vs 0.0007 ± 0.0001, p<0.05, n=4) & γ-ENaC (Figure 
40C, 0.0002 ± 0.0007 vs 0.0017 ± 0.0001, p<0.05, n=4) gene expression under 5 dyns/cm2 and 
decreased β-ENaC (Figure 40B, 0.0008 ± 0.0007 vs 0.0004 ± 0.0001, p<0.05, n=4) under 10 
dyns/cm2 & δ-ENaC (Figure 40D, 0.001 ± 0.0007 vs 0.0004 ± 0.0001, p<0.05, n=4) under 5 
dyns/cm2.  
 
Figure 40. Changing SS from LSS to OSS increases ENaC gene expression in amiloride HUVECs LSS vs OSS (0, 5 
& 10 dyns/cm2). (A) αENaC, (B) βENaC, (C) γENaC, (D) δENaC. Changing the SS pattern from LSS to OSS under 
amiloride treatment increased α-ENaC & γ-ENaC expression under 5 dyns/cm2 and decreased β-ENaC under 10 dyns/cm2 
& δ-ENaC under 5 dyns/cm2 (p<0.05) Data presented as Mean ± SEM *p<0.05, **0.01, n=4 one-way ANOVA, Sidak's 
multiple comparisons test Mann Whitney test 
 
In summary, HUVECs treated with amiloride, demonstrate an increased gene expression for 
ENaC under OSS conditions in comparison to the LSS conditions. 
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4.4.2 δ-ENaC is increased under LSS and OSS in comparison to α-ENaC with amiloride 
HUVECs treated with amiloride induced an increase in δ-ENaC gene expression under 5 
dyns/cm2 LSS, in comparison to α-ENaC (Figure 41A, 0.0007082 ± 0.0003 vs 0.000005 ± 
0.0001, p<0.001, n=4).  
HUVECs under OSS, with amiloride treatment induced an increase in δ-ENaC in gene 
expression under 10 dyns/cm2 in comparison to α-ENaC (Figure 41B, 0.0009 ± 0.0001 vs 
0.0002 ± 0.0009, p<0.001, n=4). 
 
Figure 41. ENaC gene expression in HUVECs under OSS (0, 5 & 10 dyns/cm2). (A) αENaC, (B) βENaC, (C) γENaC, 
(D) δENaC. ENaC gene expression in HUVECs under OSS was overall low and any changes exhibited in are not 
statistically significant. Data presented as Mean ± SEM **p<0.001, ****p<0.0001, n=4 one-way ANOVA, Sidak's multiple 
comparisons test Mann Whitney test. Filled and unfilled key indicate the pattern of SS, black = LSS and unfilled=OSS 
 
These results suggest that with the addition of amiloride on HUVECs under SS conditions there 
is an effect on the gene expression for delta ENaC and alpha ENaC. The gene expression for 
delta ENaC is noted to have a higher gene expression under LSS conditions. This effect is 
observed to be reversed under OSS conditions, where the it is seen that both alpha and delta 
display similar gene expressions (not statistically significant).  
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In summary this section investigated the effects of amiloride on HUVECs. This was an ideal 
replication of the use of an anti – diuretic on ECs. Amiloride as mentioned earlier is used as a 
anti-hypertensive drug and is known blocker of the ENaC channel. These experiments suggest 
that amiloride in combination with SS do play an effect on ENaC gene expression. Although it 
was not seen to decrease the gene expression, rather increase the gene expression. It would 
suggest that this response elicited by the HUVECs in ENaC gene expression would be 
compensatory within the endothelium whilst undergoing treatment for pathology.  
Whilst it is important to remember that only the gene expression for ENaC was quantified and 
that there could be differing changes occurring within the protein expression for ENaC subunits. 
The following section discusses these results and findings, in order to understand the relevance 
seen in the changes for gene expression towards physiological and pathological functions of the 
endothelium.   
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4.5. Discussion  
Previous studies have shown the epithelial sodium channel (ENaC) as a mechanosensitive ion 
channel which responds to SS in various animal systems as well as in kidney, vascular smooth 
muscle and endothelial tissue(Wang et al., 2009). SS regulates ENaC via increasing the 
channels open probability (Althaus et al. 2007) and this has been hypothesized to occur via 
conformational changes within the large extracellular domains of the channel (Shi et al 2013). 
These studies demonstrate the effect of SS on ENaC expression is limited and only ever been 
demonstrated for α-ENaC. The second aim of this project was to analyse ENaC expression with 
regards to SS and with the application of aldosterone and amiloride treatments.  
4.5.1 ENaC gene expression in HAECs 
The main purpose of using HAECs in this project was to establish an arterial EC cell culture 
and then further analyse the expression of ENaC. The following was hypothesized for HAECs: 
1. HAECs will express ENaC and increasing the magnitude of SS will lead to an increase 
in ENaC gene expression. 
2. Changing SS pattern from LSS to OSS will induce an increase in ENaC expression in 
HAECs and HUVECs  
This project was able to confirm the gene expression of ENaC subunits within HAECs. There 
were no changes in ENaC gene expression with increasing LSS, though an increase in β-ENaC 
was reported with increasing OSS. The α-ENaC to δ-ENaC expression was similar  
Based on the findings from this project, the hypothesis for HAECs was confirmed as gene 
expression of ENaC was detected and an increase in expression was reported with increasing 
SS, with changing the pattern from LSS to OSS. However, an increase in gene expression may 
not result in an increased protein expression within the ECs. This project is the first to confirm 
the expression of ENaC in human aortic endothelial cells at a preliminary stage. The gene 
expression of all four ENaC subunits, α, β, γ and δ were confirmed expressing in the cultured 
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cell line. This is opposite to what has been reported by a previous study. Ydegaard and 
colleagues quantified ENaC expression in HAECs and did not report any expression for the 
channel (Ydegaard et al., 2019). The expression levels of ENaC within HAECs were reported 
to be low with expression coming up at cycle 30 to 32; however, with the application of SS 
resulted in an increase in β-ENaC gene expression under OSS. This would suggest that overall 
HAECs have a low gene expression which is enhanced by SS. Another factor to consider is the 
house keeping gene, the Ydegaard study utilised β-actin and the analyses of the ENaC gene 
expression was done to similar cycles of β-actin. For this project, the house keeping gene 
utilised was GADPH and the analyses for ENaC gene expression was done relative to GAPDH 
expression. This difference in analyses could be why the expression for ENaC was detected, 
and the fact GAPDH was used as the house keeping gene. Malek and colleagues have reported 
the changes in β-actin when exposed to SS and the endothelial morphology changes under SS, 
due to this known effect, GAPDH was selected (Malek & Izumo, 1996).  
Following the confirmation of ENaC gene expression, HAECs were exposed to various SS 
conditions and different SS patterns (LSS and OSS). The initial stages of exposing SS to 
HAECs proved difficult; however, it was noted that low SS conditions to which HUVECs 
responded did not suit best for HAECs. The overall ENaC gene expression was low as seen in 
Figure 26, there are several factors that could explain this low expression. Factors include, small 
surface area on the ibidi chambers which the HAECs are cultured on, quality of RNA extracted 
from the cell was potentially contaminated and/or HAECs could have a physiological low 
expression of ENaC.  
An increase in β-ENaC was noted under OSS in HAECs. The mechanism behind this expression 
upregulation is not known. It is however known that β-ENaC can form channels with other 
ENaC subunits but also on its own (Kleyman et al., 1988). The composition of ENaC expression 
was not quantified as only mRNA expression was analysed. This limits the understanding of 
the role of ENaC expression within the HAEC and further experiments would be required, 
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especially with the number of experiments being only 3 experiments. This would also suggest 
that with a small number of experiments there could have been biological variability within the 
passages of HAECs due to the difficulties seen when sub-culturing the HAECs (Chapter 3).  
4.5.2 ENaC gene expression in HUVECs  
The second ECs used in this project were HUVECs as the standard model to study the effects 
of SS and for this objective, study the effect on ENaC expression. ENaC expression in HUVECs 
has been confirmed by several studies (Wang et al., 2009; Wang et al., 2013; Kusche-Vihrog 
et al., 2014a). First characterised within HUVECs as a potential mechanosensor for SS, ongoing 
investigation has led to the suggestion of ENaC’s role within the endothelium as an 
independent-mediator for vasodilation (Kusche-Vihrog et al., 2008a). Also referred to as 
endothelial-dependent-vasodilation (Kusche-Vihrog et al., 2014b). The gene expression for all 
four subunits, α, β, γ, and δ-ENaC have been confirmed in HUVECs. A preliminary project has 
also confirmed the expression of all subunits within the HUVEC culture established in the 
Fronius lab.  
The following was hypothesized for ENaC expression in HUVECs exposed to SS. 
1. Increasing the magnitude of SS will lead to an increase in ENaC gene expression in 
HUVECs. 
2. Changing SS pattern from LSS to OSS will induce an increase in ENaC gene expression 
in HAECs and HUVECs  
This project was able to demonstrate changes in the gene expression of γ-ENaC with increasing 
SS and found that with changing the SS pattern from LSS to OSS a reduction in ENaC was 
noted. Based on these findings, the hypothesis for HUVECs under SS cannot be confirmed.  
With the increase in SS, it was expected that the gene expression of ENaC would increase. This 
was not confirmed. There were several decreasing trends noted for the gene expressions of β-
ENaC and δ-ENaC under LSS and when the SS pattern was changed to OSS a decrease was 
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indicated for β-ENaC (Figure 32). To make sense of the changes going on in ENaC, the gene 
expression levels for δ-ENaC and α-ENaC were compared as it has been established that these 
two subunits share similar characteristics and form the channel with β, γ or on their own. These 
subunits have not to date been demonstrated to be expressed together. Therefore, based on this 
difference in subunits, the expression was compared, and an increasing trend was noted δ-ENaC 
in comparison to α-ENaC (Figure 33).  
An interesting result indicated in ENaC gene expression was the reduction of β-ENaC under 
OSS under 5 dyns/cm2. The functional role of β-ENaC has not been fully understood. It was 
until a recent project within the Fronius lab which indicated β-ENaC to act as a brake to reduce 
channel activity within the composition of ENaC (Baldin, unpublished data). Therefore, having 
increased expression of β-ENaC within the plasma membrane would suggest a decrease in 
sodium influx coming into the cell. However, this needs to be confirmed via western blots for 
protein expressions at the membrane and see whether ENaC expression is reduced for reduced 
conductivity. This can be exhibited in ENaC under LSS; however, with the exposure of OSS 
the expression is reduced.  
An interesting gene expression pattern was noted for ENaC in HUVECs where a suggested 
increase in gene expression of δ-ENaC could be seen for no SS and 5 dyns/cm2 LSS. This was 
observed for 10 dyns/cm2. Under OSS, an increasing trend was also seen for δ-ENaC in 
comparison to α-ENaC. It has been established that the oscillatory flow (i.e. OSS pattern) is not 
what is considered physiological and often reported in vessels of either disease or partial 
blockage. Therefore, based on these trends it could be hypothesized that a δ-ENaC presence 
could be associated with disease state. Functional studies have reported δ-ENaC to enhance 
channel activity in comparison to α-ENaC along with a higher open probability. Studies 
conducting with Xenopus oocytes have replicated δβγ-ENaC to elicit amiloride sensitive 
sodium currents 11 fold higher in comparison to that of αβγ-ENaC (Haerteis et al., 2009). This 
would therefore suggest the SS response demonstrated by δ-ENaC to be strong and with reports 
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that the δ-ENaC is more selective of sodium would indicate a greater sodium influx into the 
ECs in comparison to α-ENaC. An increase in sodium influx has been demonstrated to impair 
nitric oxide (NO) production due to causing the ECs becoming stiff.  
By increasing the SS to 10 dyns/cm2 (disease state), α-ENaC trends towards an increase gene 
expression; thus, suggesting that α-ENaC is predominant in disease states within the 
endothelium. Genetic deletion of α-ENaC from ECs has been reported decrease flow mediated 
dilation in response to increased intraluminal flow (Tarjus et al., 2017; Ashley et al., 2018). 
This highlights the importance of α-ENaC within the endothelium in the mechanotransduction 
of SS into vasodilation response. In this project, the suggested increase in gene expression of 
ENaC would indicate an increase in sodium influx occurring, this influx would allow for EC 
cell volume to increase, contributing to endothelial stiffness. Though this would have to be 
confirmed with western blot experiments. With the increase in sodium influx there would in 
turn decreasing nitric oxide production which also exacerbates endothelial stiffness. This 
stiffness has been reported to contribute to the overall generation of cardiovascular pathologies 
in particular hypertension (Davies, 2009).  
A study by Jeggle and colleagues investigated the effect of ENaC on endothelial cells, in 
particular from mice aorta. This study demonstrated that ENaC within EC determined the 
cellular mechanics and suggested a regulation on vascular function. Jeggle and colleagues then 
decided to knock down α-ENaC within the EC to measure the stiffness. Interestingly the 
stiffness was reduced in the knockdown cells (Jeggle et al., 2013). ENaC within the 
endothelium would allow for an increase in sodium influx, which in turn decreases the NO 
production and can affect the cytoskeleton structures of the cell via increasing the actin 
abundance (Fels et al., 2012). Golestaneh and colleagues were able to demonstrate ENaC 
localization with F-actin which would indicate a direct effect on cell stiffness via channel 
activity (Golestaneh et al., 2001).  
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It is important to acknowledge that the studies being referenced investigated at ENaC 
expression at protein and membrane abundance level. This project has only focused on the 
expression of ENaC at the mRNA. Therefore, the changes that have occurred at the mRNA 
level cannot indicate into protein or function. It can be hypothesized that the morphology 
changes that have been described in chapter 3 for HUVECs under SS are affected by the ENaC 
expression in either an indirect or direct pathway. An indirect signalling pathway would be 
suggested via the NO production. This is where an increase in LSS or change in SS pattern to 
OSS can result the changing the ENaC expression which in this case would be increased. This 
would lead to the downstream effects of reduced NO and in turn impair the endothelial 
dependent vasodilation. The direct pathway would be suggested via the co-localization of ENaC 
with the F-actin. This would suggest the interaction between the cytoskeleton of the cells to 
interact with the channel leading to the transactivation of the channel under stimuli and sodium 
influx. Golenstaneh and colleagues have demonstrated that without an intact cytoskeleton 
within the ECs, ENaC activity is eliminated thus suggesting an interaction between the channel 
and cell (Golestaneh et al., 2001).  
The next important step would be to translate this at the protein level. Protein was collected for 
these experiments; however the concentrations for these samples was considerably low 
(Appendix 3). Due to the low protein concentrations, protein analyses was excluded from the 
project. To further investigate the ENaC expression in HUVECs, treatments of aldosterone and 
amiloride were utilised with the application of SS and this has been discussed in the next 
section.  
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4.5.3 ENaC gene expression with aldosterone and amiloride treatment in HUVECs  
To understand the regulation of ENaC gene expression within the endothelium, aldosterone 
(10nM) and amiloride (10 µM) treatments were applied to HUVECs under SS. For this set of 
experiments, it was hypothesized that by treating HUVECs with aldosterone, it will induce an 
increase in ENaC gene expression and treating HUVECs with amiloride, it will induce a 
decrease in ENaC gene expression. This project was able to demonstrate an increase in α-ENaC 
with aldosterone treatment and increasing SS. Changing the SS pattern from LSS to OSS 
demonstrated an increase in ENaC gene expression. With HUVECs treated with amiloride, 
ENaC expression was increased and when the SS pattern was changed from LSS to OSS, an 
increase in α-ENaC and γ-ENaC gene expression was indicated.  
Based on these findings, the hypothesis cannot be confirmed as the amiloride treatment induced 
an increase in the ENaC expression. This was hypothesized based on a study by Kusche-Vihrog 
and colleagues (2014) where a decrease in ENaC expression was reported following the 
application of amiloride. However, it is important to note that this study analysed the changes 
in ENaC expression at the plasma membrane and this project analysed the changes at the mRNA 
level.  
For the aldosterone treated HUVECs an increase was indicated in ENaC expression; however, 
this was only for α-ENaC and δ-ENaC in comparison to the other subunits. This was not 
expected as aldosterone has been shown to increase ENaC protein expression (Kusche-Vihrog 
et al., 2008a; Jeggle et al., 2013; Martinez-Lemus et al., 2017). It would be important to 
consider these results as preliminary due to the series of optimisation required to obtain a 
confluent cell culture. As mentioned in chapter 3, a control for aldosterone treatment was the 
removal of the fetal bovine serum (FBS) to ensure the effect on ENaC expression was solely 
that of aldosterone. However, impaired cell survival and distress to the HUVEC, confluency 
and obtaining feasible amounts of cell lysate meant FBS was added back into the medium. 
Therefore, the concentration of 10nM of aldosterone may not have been enough to influence 
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ENaC expression over a period of 24 hrs. Oberleithner and colleagues investigated the effect 
of aldosterone on ECs which lead to swelling of the cell (has been reported in Chapter 3), this 
study did raise an important point with regards to the concentration of aldosterone (Oberleithner 
et al., 2004a). Oberleithner and colleagues, described the definition of the effective 
physiological concentration as “difficult”. This is because plasma concentrations of aldosterone 
are most likely to differ from origin of secretion i.e. paracrine secretion (Oberleithner et al., 
2004b). Another study by Oberleithner and colleagues used a concentration of 10 0nM to exert 
changes within the HUVEC volume (Oberleithner et al., 2003). This is 10 times less that what 
they used in the study mentioned above and to what this project has used.  
With the application of OSS, the expression of ENaC with aldosterone was significantly 
increased for α-ENaC and trended towards an increase for β-ENaC in comparison to non-treated 
HUVECs. Both γ and δ-ENaC were observed to have low gene expression under 5 dyns/cm2. 
This indicates aldosterone combined with OSS, increases ENaC expression. The gene 
expression can only measure the increase in ENaC from the genomic phase (i.e. late phase). 
Therefore, at the protein level it can be hypothesized that a greater increase would have 
occurred. Although, δ-ENaC is reported to have a higher open probability, Althaus and 
colleagues previously reported that under SS, δ-ENaC response was weaker in comparison to 
that of α-ENaC (Althaus et al., 2007). Therefore, the increase in α-ENaC under OSS is 
supported in the context that δ-ENaC has become saturated in its response to SS, so α-ENaC 
compensates for δ-ENaC allowing for sodium to influx into the cell.  
The mechanism behind aldosterone’s effect has already been well established with its early 
phase and late phase. The early phase is also considered the non-genomic phase where ENaC 
at the plasma membrane is inhibited from being recycled (Wildling et al., 2009). The late phase, 
also known as the genomic phase allows for the transcription and synthesis of ENaC into the 
cytosol and plasma membrane (Kusche-Vihrog et al., 2014b). One of the kinases that is 
activated by aldosterone is SGK1 (serum and glucocorticoid-regulated kinase 1). SGK1 directly 
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phosphorylates recycling proteins interacting with ENaC, increasing ENaC expression at the 
apical membrane. Another effect of SGK1 is via increasing the transcription of ENaC mRNA 
(Fels et al., 2010). An ideal control to check the aldosterone effect was occurring would have 
been by quantifying the expression of SKG1 as a positive control. No SGK1 expression or low 
expression could have provided the information that the concentration used for HUVEC was 
not optimal enough to generate a response. Although Kusche-Vihrog and co-workers were able 
to establish a response using 10 nM of aldosterone within HUVECs. These highlights further 
experiments are required to understand the effects of aldosterone on ENaC in HUVECs.  
For amiloride treated HUVECs, an interesting increase in ENaC gene expression was noted. 
This increase was for α-ENaC under LSS, with 10 dyns/cm2 and for γ and δ-ENaC under OSS. 
When the SS pattern was compared for LSS and OSS a reported increase in gene expression 
was noted for α-ENaC and γ-ENaC. A decrease in gene expression was reported for β-ENaC 
and δ-ENaC for OSS in comparison to LSS. It is quite difficult to explain the changes in ENaC 
expression with regards to amiloride application. There are limited studies that have reported 
the effects of amiloride on ENaC expression. The study by Kusche-Vihrog and colleagues 
(2008a) reported a reduction in ENaC expression. In an animal study by Marshall and 
colleagues, mice were fed a western diet and then treated the animals with a low of dose 
amiloride. This was reported to induce a reduction in ENaC protein expression in ECs of the 
mesenteric arteries (Marshall et al., 2017). The difference between these two studies and this 
project is the ENaC protein levels expression was quantified at the plasma membrane, whereas 
this project focused on the mRNA It can be suggested that the increase seen in HUVECs treated 
with amiloride is induced due to the potential blockade of ENaC channels are the plasma 
membrane which in theory could signal the cell to transcribe for ENaC to maintain an 
electrolyte balance within the endothelium. Another possible explanation to these results could 
be that with the effect of SS already on the endothelium, amiloride is potentially improving 
endothelial dependent function by inducing the production of NO as reported in the mice model 
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which had improved endothelial function with the application of amiloride (Martinez-Lemus et 
al., 2017) 
4.5.5 Future directions.  
Ideally, more experimental replicates are required to ensure the changes in ENaC expression 
are occurring. With the addition of replicates, investigating the protein expression of ENaC 
would be important under SS and with the treatments of aldosterone and amiloride. By 
quantifying the protein expression, it would ideal to characterise the changes that are occurring 
with regards to the different conditions and treatments.  
The focus shift of ENaC expression in HUVECs to an arterial EC i.e. HAEC would be 
appropriate to investigate how aldosterone and amiloride effects ENaC expression. This 
understanding would enable for a suitable translational model of ENaC expression in 






















The aim of this project was to investigate the expression of ENaC and the change in 
morphology in endothelial cells, under shear stress with the addition of aldosterone and 
amiloride.   
Overall, this project has been able to demonstrate the morphological changes ECs undergo in 
response to SS. EC alignment to the direction of flow has been demonstrated by various studies 
indicating the possible involvement of cytoskeletal proteins. With the addition of amiloride and 
aldosterone treatments, the EC morphological changes observed provides an insight into how 
ECs could react with the introduction of hormones and drugs in the plasma. The most unique 
aspect to this project has been the ability to replicate flow using a perfusion system to study the 
effects of SS on morphology. This project was then able to narrow the investigation down to 
the expression of ENaC within ECs as a potential mechanosensor that facilitates a multitude of 
signalling pathways.  
This project was able to demonstrate ENaC expression within HAECs and HUVECs. With the 
administration of either aldosterone or amiloride under SS, ENaC expression was found to 
increase. This increase in ENaC expression following amiloride treatment was unexpected as it 
was initially hypothesized to observe a decrease.  
ENaC is vital for endothelial function and is a potential mechanosensor involved in regulating 
endothelial behaviour in response to mechanical stimuli. Although further studies are required 
to examine this behaviour however this project was the first to demonstrate ENaC expression 
in human aortic endothelial cells.  
In conclusion, HAECs and HUVECs expression ENaC genes. HAECs respond to OSS and 
increase in ENaC gene expression with OSS. HUVECs respond to LSS, with minimal changes 
in ENaC gene expression. The aldosterone and amiloride treatments for HUVECs revealed that 
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Appendix 3- Protein expression for ENaC subunits.  
An aspect of quantifying ENaC expression was to do so at the protein level. All cell lysates for 
HAECs and HUVECs were collated post LSS and OSS experiments. One of the issues that 
became apparent regarding the lysates, was the amount of protein concentration. As shown in 
Figure 37, the concentration of protein per sample was very low. Detection of ENaC subunits 
at the protein level was not possible as there was not enough protein to load for a SDS-page 
electrophoresis gel, which requires a ~30-40µg/µl concentration.  
Ideally, quantification of protein expression would have an appropriate confirmation of the 
changes that have been exhibited at the mRNA level. It is known that changes at mRNA level 
do differ to that of protein and it also important to acknowledge that any ENaC proteins stored 
in vesicles near the plasma membrane would have not been detected at mRNA level.  
 
Protein quantification of HUVEC and HAEC samples. Bradford assay results indicating concentrations of cell 
lysates (A) HUVECs (B) HUVECs with aldosterone (C) HUVECs with amiloride (D) HAECs).  
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